CN109125617A - A kind of Rhizoma Gastrodiae composition being effectively improved sleep and preparation method, preparation and application - Google Patents
A kind of Rhizoma Gastrodiae composition being effectively improved sleep and preparation method, preparation and application Download PDFInfo
- Publication number
- CN109125617A CN109125617A CN201811155340.6A CN201811155340A CN109125617A CN 109125617 A CN109125617 A CN 109125617A CN 201811155340 A CN201811155340 A CN 201811155340A CN 109125617 A CN109125617 A CN 109125617A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- rhizoma gastrodiae
- ethyl alcohol
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 172
- 230000007958 sleep Effects 0.000 title claims abstract description 84
- 238000002360 preparation method Methods 0.000 title claims abstract description 59
- 230000001976 improved effect Effects 0.000 title claims abstract description 42
- 239000000284 extract Substances 0.000 claims abstract description 239
- 241001632410 Eleutherococcus senticosus Species 0.000 claims abstract description 75
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 70
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 70
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 70
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 70
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 70
- 240000008866 Ziziphus nummularia Species 0.000 claims abstract description 63
- 239000002994 raw material Substances 0.000 claims abstract description 37
- 239000003814 drug Substances 0.000 claims abstract description 26
- 229940079593 drug Drugs 0.000 claims abstract description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 304
- 235000019441 ethanol Nutrition 0.000 claims description 166
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 80
- 238000000605 extraction Methods 0.000 claims description 77
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 72
- 238000001914 filtration Methods 0.000 claims description 48
- 239000002775 capsule Substances 0.000 claims description 47
- 239000002904 solvent Substances 0.000 claims description 44
- 238000000034 method Methods 0.000 claims description 40
- 239000000843 powder Substances 0.000 claims description 40
- 239000000377 silicon dioxide Substances 0.000 claims description 40
- 239000011248 coating agent Substances 0.000 claims description 39
- 238000000576 coating method Methods 0.000 claims description 39
- 238000010992 reflux Methods 0.000 claims description 39
- 235000019359 magnesium stearate Nutrition 0.000 claims description 36
- 239000011812 mixed powder Substances 0.000 claims description 36
- 239000011122 softwood Substances 0.000 claims description 36
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 35
- 238000010438 heat treatment Methods 0.000 claims description 35
- 229920002785 Croscarmellose sodium Polymers 0.000 claims description 28
- 239000003795 chemical substances by application Substances 0.000 claims description 26
- 239000002245 particle Substances 0.000 claims description 26
- 229960001681 croscarmellose sodium Drugs 0.000 claims description 25
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 235000020985 whole grains Nutrition 0.000 claims description 24
- 238000011049 filling Methods 0.000 claims description 23
- 239000000706 filtrate Substances 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 23
- 210000000582 semen Anatomy 0.000 claims description 20
- 238000001291 vacuum drying Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000006228 supernatant Substances 0.000 claims description 16
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 15
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 15
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 15
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 15
- 229920000881 Modified starch Polymers 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 229920000573 polyethylene Polymers 0.000 claims description 12
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims description 11
- 206010022437 insomnia Diseases 0.000 claims description 11
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 10
- 238000004132 cross linking Methods 0.000 claims description 10
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 10
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 10
- 241000305491 Gastrodia elata Species 0.000 claims description 9
- 201000010099 disease Diseases 0.000 claims description 9
- 238000012856 packing Methods 0.000 claims description 9
- 230000004584 weight gain Effects 0.000 claims description 9
- 235000019786 weight gain Nutrition 0.000 claims description 9
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 claims description 8
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 8
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 claims description 8
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 claims description 8
- 241000607479 Yersinia pestis Species 0.000 claims description 8
- 230000006378 damage Effects 0.000 claims description 8
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 8
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 8
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 8
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 8
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 8
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 claims description 8
- 235000013372 meat Nutrition 0.000 claims description 8
- -1 pulvis Substances 0.000 claims description 8
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 claims description 8
- 238000005259 measurement Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 206010013786 Dry skin Diseases 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 150000004665 fatty acids Chemical class 0.000 claims 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 11
- 230000003000 nontoxic effect Effects 0.000 abstract description 11
- 235000013305 food Nutrition 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 4
- 235000013402 health food Nutrition 0.000 abstract description 3
- 231100000820 toxicity test Toxicity 0.000 abstract description 2
- 238000009602 toxicology test Methods 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 123
- 241000699666 Mus <mouse, genus> Species 0.000 description 67
- 241000700159 Rattus Species 0.000 description 53
- 241001465754 Metazoa Species 0.000 description 51
- 238000002474 experimental method Methods 0.000 description 26
- 241000256856 Vespidae Species 0.000 description 21
- 230000036578 sleeping time Effects 0.000 description 20
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 19
- 241000282414 Homo sapiens Species 0.000 description 18
- 230000004620 sleep latency Effects 0.000 description 18
- 229960000796 barbital sodium Drugs 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 17
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 238000002156 mixing Methods 0.000 description 15
- 210000003743 erythrocyte Anatomy 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 239000013642 negative control Substances 0.000 description 12
- 230000008859 change Effects 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 238000001543 one-way ANOVA Methods 0.000 description 9
- 239000008223 sterile water Substances 0.000 description 9
- 231100000403 acute toxicity Toxicity 0.000 description 7
- 230000007059 acute toxicity Effects 0.000 description 7
- 238000010171 animal model Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 210000001672 ovary Anatomy 0.000 description 7
- 231100000027 toxicology Toxicity 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- 244000144993 groups of animals Species 0.000 description 6
- 230000002757 inflammatory effect Effects 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 210000001550 testis Anatomy 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 210000005239 tubule Anatomy 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 241000607142 Salmonella Species 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 230000000147 hypnotic effect Effects 0.000 description 5
- 231100000572 poisoning Toxicity 0.000 description 5
- 230000000607 poisoning effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 4
- 238000004820 blood count Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 230000002489 hematologic effect Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010016654 Fibrosis Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241001247821 Ziziphus Species 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 231100000673 dose–response relationship Toxicity 0.000 description 3
- 230000004761 fibrosis Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000000885 nephron Anatomy 0.000 description 3
- 210000000633 nuclear envelope Anatomy 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000007863 steatosis Effects 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- CFRFHWQYWJMEJN-UHFFFAOYSA-N 9h-fluoren-2-amine Chemical compound C1=CC=C2C3=CC=C(N)C=C3CC2=C1 CFRFHWQYWJMEJN-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000028527 righting reflex Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- DGSPEKJPKBXKSL-UHFFFAOYSA-N 2,4,7-trinitrofluoren-1-one Chemical group [O-][N+](=O)C1=CC=C2C3=C([N+](=O)[O-])C=C([N+]([O-])=O)C(=O)C3=CC2=C1 DGSPEKJPKBXKSL-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 206010003084 Areflexia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000305492 Gastrodia Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- AQLLBJAXUCIJSR-UHFFFAOYSA-N OC(=O)C[Na] Chemical compound OC(=O)C[Na] AQLLBJAXUCIJSR-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 241001661920 Telosma Species 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960001301 amobarbital Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- WUDFEXSJURUGSD-UHFFFAOYSA-N anthracene-1,8-diol Chemical compound C1=CC(O)=C2C=C3C(O)=CC=CC3=CC2=C1 WUDFEXSJURUGSD-UHFFFAOYSA-N 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000002394 ovarian follicle Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- WRLGYAWRGXKSKG-UHFFFAOYSA-M phenobarbital sodium Chemical compound [Na+].C=1C=CC=CC=1C1(CC)C(=O)NC([O-])=NC1=O WRLGYAWRGXKSKG-UHFFFAOYSA-M 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 102000014898 transaminase activity proteins Human genes 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Rhizoma Gastrodiae composition for being effectively improved sleep and preparation methods, preparation and application, the composition includes the raw material of following parts by weight: 4-16 parts of Rhizoma Gastrodiae extract, 16-33 parts of Wild jujube seeds extract, 13-33 parts of siberian Ginseng P.E, 8-25 parts of extract of licorice root.Composition of the invention has the advantages that safely, effectively, wide application of the crowd using dual-purpose of drug and food and the Chinese medicine that can be used for health food as raw material.Efficacy assessments and toxicology test show that the composition has remarkable efficacy, and safety non-toxic for improving sleep function.
Description
Technical field
The invention belongs to technical field of health care food, and in particular to a kind of Rhizoma Gastrodiae composition for being effectively improved sleep and preparation
Method, preparation and application.
Background technique
Sleep is the particularly important a part of health, and sufficient sleep helps to improve memory and creativity, subtract
It light weight and relieves stress, obtains more outstanding school grade, improve working efficiency, the service life can also be extended.In recent years, with
People's life, the increase of working and learning pressure, the burden at heart of people, the quantity of insomniac is on constantly
It rises, insomnia has seriously affected people's lives, work and physical and mental health.WHO's research shows that: the whole world there are about 27% people incidents
By the puzzlement of sleep disorder, studies in China is shown: there are about 300,000,000 adults to suffer from insomnia for China, and the disease incidence of serious insomnia is
9.38%.Although the tranquilizing and allaying excitement hypnotic drug based on Western medicine has extraordinary curative effect, much all there is side effect,
It is easy habituation, the obvious disadvantage of after effect, some excessive uses are also possible to threat to life.
Rhizoma Gastrodiae (Gastrodia elata) also known as rhizoma gastrodiae are the dry tuber of orchid Rhizoma Gastrodiae.Rhizoma Gastrodiae existing more than 2,000
Year applicating history, the successive dynasties are on the books and are classified as top grade, Shennong's Herbal cloud: long term usage benefiting energy, and long yin fertilizer is good for, increasing of making light of one's life by commiting suicide
Year.Modern pharmacological studies have shown that Rhizoma Gastrodiae has the function of tranquilizing soporific, improves sleep.In the prior art, it is multiple to have other Rhizoma Gastrodiaes
The products such as square capsule, but there is larger problem, some effects are not significant enough, need to largely take, and What is more can bring pair
Reaction." bier battalion health can a piece " think the interpretation of the cause, onset and process of an illness of people " night does not set " be " qi and blood of the old declines, and muscle is withered, and air flue is puckery, five
Dirty gas phase is fought, deficiency of nutrient QI with inner disturbance of defensive QI, brightlessness in the daytime, and night is insomnia ".Occur physiological function with advancing age and subtract
It moves back and the influence of various chronic diseases to hepatic and renal function declines.Blood stored in the liver, kidney storing essence, caused by liver and kidney deficiency, asthenia of essence and blood, mind dystrophy
It then sleeps uneasiness, the deficiency of liver-yin and kidney-yin, liver-yang hyperactivity upsets the mind also to having a sleepless night.And the prior art not can solve above-mentioned ask
Topic.
For above situation, it is necessary to invent a kind of Rhizoma Gastrodiae composition for being effectively improved sleep and preparation method, preparation with
Using.Rhizoma Gastrodiae, semen ziziphi spinosae, wilsonii and Radix Glycyrrhizae are had not yet to see with the use of the report for improving sleep.
Summary of the invention
The first object of the present invention is to provide a kind of Rhizoma Gastrodiae composition for being effectively improved sleep, and second is designed to provide
A kind of preparation method for the Rhizoma Gastrodiae composition being effectively improved sleep, third are designed to provide a kind of Rhizoma Gastrodiae for being effectively improved sleep
The preparation of composition, the 4th is designed to provide a kind of application of Rhizoma Gastrodiae composition for being effectively improved sleep.
The first object of the present invention is achieved in that the raw material including following parts by weight: 4-16 parts of Rhizoma Gastrodiae extract, sour
16-33 parts of jujube kernel extract, 13-33 parts of siberian Ginseng P.E, 8-25 parts of extract of licorice root.
The second object of the present invention be achieved in that the following steps are included:
1) raw material preparation: taking that meat is thick and solid, Gastrodia Elata Stem Tuber of no disease and pests harm, 55-65 DEG C low temperature drying 24 hours, crush, cross 8-
12 meshes, adding the 8-12 times of 65-75% ethyl alcohol measured is Extraction solvent, and heating and refluxing extraction 2-4 times is 0.5-1.5 hours each, is closed
And extracting solution, ethyl alcohol is recovered under reduced pressure, is concentrated into and is equivalent to crude drug 0.4-0.6g/mL, 4000-6000 r/min is centrifuged 10-20 points
Clock takes supernatant, is concentrated under reduced pressure into and is equivalent to crude drug 3-5g/mL, adds ethyl alcohol to alcohol content 65-75%, stands 22-26h, filter
It crosses, adds 35-45%NaOH solution tune pH value to 8.0, stand 22-26h, filtration, filtrate is concentrated under reduced pressure into paste in 45-55 DEG C
And ethyl alcohol is recycled, 45-55 DEG C or less vacuum drying obtains Rhizoma Gastrodiae extract, spare;Semen ziziphi spinosae seed is taken, is crushed into powder, 7- is added
The 55-65% ethyl alcohol of 9 times of amounts is Extraction solvent, heating and refluxing extraction 2-4 hours after impregnating 25-35 minutes, filtration;5-7 times is added to measure
55-65% ethyl alcohol be Extraction solvent, heating and refluxing extraction 1-3 times is 1.5-2.5 hours each;Filtration, combined extract, decompression
Ethyl alcohol is recycled, being concentrated into relative density is 1.20-1.24, adds ethyl alcohol to alcohol content 65-75%, stands 22-26h, filter, filter
Liquid is concentrated under reduced pressure into paste in 45-55 DEG C and recycles ethyl alcohol, and 45-55 DEG C or less vacuum drying obtains Wild jujube seeds extract, standby
With;Wilsonii rhizome is taken, is cleaned out, is crushed into powder, adding the 8-12 times of 75-85% ethyl alcohol measured is Extraction solvent, is heated to reflux and mentions
It takes 2-4 hours, filters;Adding the 8-12 times of 70-80% ethyl alcohol measured is Extraction solvent, heating and refluxing extraction 1-3 times, each 1.5-2.5
Hour;Ethyl alcohol is recovered under reduced pressure in filtration, combined extract, and being concentrated into relative density is 1.20-1.24, adds ethyl alcohol to alcohol content
65-75% stands 22-26h, filtration, and filtrate is concentrated under reduced pressure into paste in 45-55 DEG C and recycles ethyl alcohol, and 45-55 DEG C or less true
Sky is dry, obtains siberian Ginseng P.E, spare;It takes that matter is hard, taste is pure, Radix Glycyrrhizae without mildew, moisturizes, be sliced, add water to cook 2-4
Secondary, 1.5-2.5 hours each, collecting decoction, standing overnight makes to precipitate, and supernatant is taken to be concentrated into paste, and measurement liquiritin contains
Must not measure less than 0 .5%, glycyrrhizic acid must not be less than 7.0%, obtain extract of licorice root, spare;
2) mix: by raw material obtained in step (1) first cross 60 meshes, then weigh respectively formula rate Rhizoma Gastrodiae extract,
Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root are sufficiently mixed uniformly.
The third object of the present invention be achieved in that the preparation of the Rhizoma Gastrodiae composition for being effectively improved sleep be
The auxiliary material pharmaceutically received is added in the composition and is prepared into capsule, tablet, pulvis, granule, liquid preparation, ball
Agent.
The fourth object of the present invention is achieved in that described having improves the Rhizoma Gastrodiae composition of function in prevention/auxiliary
Help the application on treatment of insomnia patients.
Compared with prior art, the present invention has following technical effect that
1, composition of the invention has safe and effective using dual-purpose of drug and food and the Chinese medicine that can be used for health food as raw material
Advantage, wide application of the crowd.Efficacy assessments and toxicology test show that the composition has significant function for improving sleep function
Effect, and safety non-toxic.
2, direction treatment insomnia of the present invention from tonify the liver and kidney, calm down liver-yang, mental-tranquilization, mutually auxiliary phase between each raw material
At in this formula, wilsonii pharmacological property temperature, acrid flavour, slight bitter is nontoxic, enters spleen, kidney channel, can strengthen the body resistance to consolidate the constitution, kidney and spleen invigorating, intelligence development peace
Mind is monarch drug in a prescription;Rhizoma Gastrodiae safety relieves dizziness, high fever, infantile convulsions, epilepsy, etc. checking exuberance of yang, is ministerial drug;Semen ziziphi spinosae nourishing the liver, calming heart, tranquilizing the mind are adjutant;Radix Glycyrrhizae coordinating the drug actions of a prescription.Four
Medicine play altogether tonify the liver and kidney, be calming the liver, antitoxic heart-soothing and sedative the benefits of.Meanwhile modern pharmacological research proves, wilsonii has adjusting maincenter
Nervous system excitability fights central excitation caused by caffeine and extends the sleeping time of amobarbital;Semen ziziphi spinosae can contract
Short sleep latency.Therefore, four medicines share can adjust body function state on the whole, fundamentally improve sleep quality.
3, the present invention first prepares Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, preparation side
The advantages that method makes full use of modern Chinese herbal medicine processing technology means, has and extracts completely, easy to operate, and extractant is non-toxic, obtains
Extract and medicinal extract guarantee that the effective component in raw material is not easy to lose, while convenient for saving.
Detailed description of the invention
Fig. 1 is the preparation technology flow chart of capsule or tablet of the invention;
Fig. 2 is the production technological process of Rhizoma Gastrodiae extract of the invention;
Fig. 3 is the production technological process of Wild jujube seeds extract of the invention;
Fig. 4 is the production technological process of siberian Ginseng P.E of the invention.
Specific embodiment
Below with reference to embodiment and attached drawing, the present invention is further illustrated, but is not subject in any way to the present invention
Limitation, based on present invention teach that it is made it is any transform or replace, all belong to the scope of protection of the present invention.
The Rhizoma Gastrodiae composition of the present invention for being effectively improved sleep, the raw material including following parts by weight: Rhizoma Gastrodiae extract
4-16 parts, 16-33 parts of Wild jujube seeds extract, 13-33 parts of siberian Ginseng P.E, 8-25 parts of extract of licorice root.
Further, the composition includes the raw material of following parts by weight: 8-16 parts of Rhizoma Gastrodiae extract, Wild jujube seeds extract
25-33 parts, 13-25 parts of siberian Ginseng P.E, 8-16 parts of extract of licorice root, 10-30 parts of pregelatinized starch, cross-linked carboxymethyl cellulose
1.0-5.0 parts of sodium, 0.5-1.5 parts of silica, 0.5-1.5 parts of magnesium stearate.
Further, the composition includes the raw material of following parts by weight: 8-16 parts of Rhizoma Gastrodiae extract, Wild jujube seeds extract
25-33 parts, 13-25 parts of siberian Ginseng P.E, 8-16 parts of extract of licorice root, 32-38 parts of microcrystalline cellulose, cross-linked carboxymethyl cellulose
2.0-3.0 parts of sodium, 6.0-10 parts of silica, 6.0-10 parts of magnesium stearate, 2.5-3.5 parts of coating powder.
The preparation method of the Rhizoma Gastrodiae composition of the present invention for being effectively improved sleep, comprising the following steps:
1) raw material preparation: taking that meat is thick and solid, Gastrodia Elata Stem Tuber of no disease and pests harm, 55-65 DEG C low temperature drying 24 hours, crush, cross 8-
12 meshes, adding the 8-12 times of 65-75% ethyl alcohol measured is Extraction solvent, and heating and refluxing extraction 2-4 times is 0.5-1.5 hours each, is closed
And extracting solution, ethyl alcohol is recovered under reduced pressure, is concentrated into and is equivalent to crude drug 0.4-0.6g/mL, 4000-6000 r/min is centrifuged 10-20 points
Clock takes supernatant, is concentrated under reduced pressure into and is equivalent to crude drug 3-5g/mL, adds ethyl alcohol to alcohol content 65-75%, stands 22-26h, filter
It crosses, adds 35-45%NaOH solution tune pH value to 8.0, stand 22-26h, filtration, filtrate is concentrated under reduced pressure into paste in 45-55 DEG C
And ethyl alcohol is recycled, 45-55 DEG C or less vacuum drying obtains Rhizoma Gastrodiae extract, spare;Semen ziziphi spinosae seed is taken, is crushed into powder, 7- is added
The 55-65% ethyl alcohol of 9 times of amounts is Extraction solvent, heating and refluxing extraction 2-4 hours after impregnating 25-35 minutes, filtration;5-7 times is added to measure
55-65% ethyl alcohol be Extraction solvent, heating and refluxing extraction 1-3 times is 1.5-2.5 hours each;Filtration, combined extract, decompression
Ethyl alcohol is recycled, being concentrated into relative density is 1.20-1.24, adds ethyl alcohol to alcohol content 65-75%, stands 22-26h, filter, filter
Liquid is concentrated under reduced pressure into paste in 45-55 DEG C and recycles ethyl alcohol, and 45-55 DEG C or less vacuum drying obtains Wild jujube seeds extract, standby
With;Wilsonii rhizome is taken, is cleaned out, is crushed into powder, adding the 8-12 times of 75-85% ethyl alcohol measured is Extraction solvent, is heated to reflux and mentions
It takes 2-4 hours, filters;Adding the 8-12 times of 70-80% ethyl alcohol measured is Extraction solvent, heating and refluxing extraction 1-3 times, each 1.5-2.5
Hour;Ethyl alcohol is recovered under reduced pressure in filtration, combined extract, and being concentrated into relative density is 1.20-1.24, adds ethyl alcohol to alcohol content
65-75% stands 22-26h, filtration, and filtrate is concentrated under reduced pressure into paste in 45-55 DEG C and recycles ethyl alcohol, and 45-55 DEG C or less true
Sky is dry, obtains siberian Ginseng P.E, spare;It takes that matter is hard, taste is pure, Radix Glycyrrhizae without mildew, moisturizes, be sliced, add water to cook 2-4
Secondary, 1.5-2.5 hours each, collecting decoction, standing overnight makes to precipitate, and supernatant is taken to be concentrated into paste, and measurement liquiritin contains
Must not measure less than 0 .5%, glycyrrhizic acid must not be less than 7.0%, obtain extract of licorice root, spare;
2) mix: by raw material obtained in step (1) first cross 60 meshes, then weigh respectively formula rate Rhizoma Gastrodiae extract,
Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root are sufficiently mixed uniformly.
The preparation of the Rhizoma Gastrodiae composition of the present invention for being effectively improved sleep is that pharmacy is added in the composition
The auxiliary material of upper receiving is prepared into capsule, tablet, pulvis, granule, liquid preparation, pill.
Further, the capsule includes the raw material of following parts by weight: 8-16 parts of Rhizoma Gastrodiae extract, semen ziziphi spinosae extracts
25-33 parts of object, 13-25 parts of siberian Ginseng P.E, 8-16 parts of extract of licorice root, 10-30 parts of pregelatinized starch, cross-linked carboxymethyl fiber
Plain sodium 1.0-5.0 parts, 0.5-1.5 parts of silica, 0.5-1.5 parts of magnesium stearate;The preparation method of the capsule includes
Following steps:
1) it is sieved: Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root is crossed into 60 meshes respectively, it is spare;
2) it weighs: weighing Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, pregelatinated by formula rate
Starch, croscarmellose sodium, silica, magnesium stearate are spare;
3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, pregelatinized starch, crosslinking
Sodium carboxymethylcellulose, silica mix 25 ~ 35min, obtain mixed powder;
4) softwood processed: mixed powder softwood is added in 65-75% ethyl alcohol, additional amount is that 65-75% ethyl alcohol is added in every 100g mixed powder
28 ~ 32ml, be uniformly mixed, be allowed to hold it is agglomerating, gently pinch i.e. dissipate;
5) it pelletizes, dry, whole grain: the softwood made being pelletized by 16-20 mesh, then places 50 ~ 60 DEG C of dryings in baking oven
1.5 ~ 2.5h crosses 16-20 mesh sieve;
6) total mix: the particle after whole grain is mixed into 3 ~ 7min with magnesium stearate, obtains total hybrid particles;
7) capsule is filling: gained always being mixed granule filling, obtains capsule.
Further, the filling specification of the capsule is 0.6g/, is filled in 0# capsule, packing specification 60
Grain/bottle is packed using oral stable medicinal polythene bottle with high density;The amount and eating method of the capsule be
2 times a day, 2 tablets each time, each 1 time of morning and evening.
Further, the tablet includes the raw material of following parts by weight: 8-16 parts of Rhizoma Gastrodiae extract, Wild jujube seeds extract
25-33 parts, 13-25 parts of siberian Ginseng P.E, 8-16 parts of extract of licorice root, 32-38 parts of microcrystalline cellulose, cross-linked carboxymethyl cellulose
2.0-3.0 parts of sodium, 6.0-10 parts of silica, 6.0-10 parts of magnesium stearate, 2.5-3.5 parts of coating powder;The system of the tablet
Preparation Method the following steps are included:
1) be sieved: Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root cross 60 meshes respectively, spare;
2) weigh: it is fine to weigh Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, crystallite by formula rate
It is spare to tie up element, croscarmellose sodium, silica, magnesium stearate, coating powder;
3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, microcrystalline cellulose, crosslinking
Sodium carboxymethylcellulose, silica mix 25 ~ 35min, obtain mixed powder;
4) softwood processed: mixed powder softwood is added in 65-75% ethyl alcohol, additional amount is that 65-75% ethyl alcohol is added in every 100g mixed powder
28 ~ 32ml, be allowed to hold it is agglomerating, gently pinch i.e. dissipate;
5) it pelletizes, dry, whole grain: the softwood made being pelletized by 16-20 mesh, then places 50 ~ 60 DEG C of dryings in baking oven
1.5 ~ 2.5h crosses 16-20 mesh sieve;
6) total mix: the particle after whole grain is mixed into 3 ~ 7min with magnesium stearate, obtains total hybrid particles;
7) granulation will always tabletting, coating, bottling: be mixed;Then coating powder is configured to 8-12% coating with 65-75% ethyl alcohol
Liquid is coated tabletting, coating weight gain 2-4%, bottling.
Further, the tabletting specification of the tablet is 0.6g/ piece, and the bottling is using the medicinal height of oral administration solid
Density polyethylene bottle carries out, and bottling specification is 80 pieces/bottle;The amount and eating method of the tablet: 2 times a day, every time 2
Piece, each 1 time sooner or later.
The application of the present invention that there is the Rhizoma Gastrodiae composition for improving function on prevention/auxiliary treatment of insomnia disease.
Embodiment 1
A kind of Rhizoma Gastrodiae composition being effectively improved sleep, the raw material including following parts by weight: 10 parts of Rhizoma Gastrodiae extract, semen ziziphi spinosae mentions
Take 24 parts of object, 25 parts of siberian Ginseng P.E, 16 parts of extract of licorice root.
A kind of preparation method for the Rhizoma Gastrodiae composition being effectively improved sleep, it is characterised in that the following steps are included:
1) raw material preparation: taking that meat is thick and solid, Gastrodia Elata Stem Tuber of no disease and pests harm, 60 DEG C low temperature drying 24 hours, crush, cross 10 mesh
Sieve, adding 70% ethyl alcohol of 10 times of amounts is Extraction solvent, and 3 hours of heating and refluxing extraction, 1 hour every time, combined extract depressurized
Ethyl alcohol is recycled, is concentrated into and is equivalent to crude drug 0.5g/mL, 5000 r/min are centrifuged 15 minutes, are taken supernatant, are concentrated under reduced pressure into phase
When adding ethyl alcohol to alcohol content 70% in crude drug 4g/mL, 24 h of standing are filtered, and are added 40%NaOH solution tune pH value to 8.0, are stood
For 24 hours, it filters, filtrate is concentrated under reduced pressure into paste in 50 DEG C and recycles ethyl alcohol, and 50 DEG C or less vacuum drying obtain Rhizoma Gastrodiae extraction
Object, it is spare;Semen ziziphi spinosae seed is taken, is crushed into powder, adding 60% ethyl alcohol of 8 times of amounts is Extraction solvent, is heated back after impregnating 0.5 hour
Stream extracts 3 hours, filtration;Add 60% ethyl alcohol of 6 times of amounts for Extraction solvent, heating and refluxing extraction 2 times, every time 2 hours;Filtration is closed
And extracting solution, ethyl alcohol is recovered under reduced pressure, being concentrated into relative density is 1.20, adds ethyl alcohol to alcohol content 70%, and standing for 24 hours, filters,
Filtrate is concentrated under reduced pressure into paste in 50 DEG C and recycles ethyl alcohol, and 50 DEG C or less vacuum drying obtain Wild jujube seeds extract, spare;
Wilsonii rhizome is taken, is cleaned out, is crushed into powder, adds 80% ethyl alcohol of 10 times of amounts for Extraction solvent, heating and refluxing extraction 3 hours,
Filtration;Add 75% ethyl alcohol of 10 times of amounts for Extraction solvent, heating and refluxing extraction 2 times, every time 2 hours;Filtration, combined extract subtract
Push back receipts ethyl alcohol, being concentrated into relative density is 1.20-1.24, adds ethyl alcohol to alcohol content 70%, stand filtration for 24 hours, filtrate in
50 DEG C are concentrated under reduced pressure into paste and recycle ethyl alcohol, and 50 DEG C or less vacuum drying obtain siberian Ginseng P.E, spare;Take matter it is hard,
Taste is pure, Radix Glycyrrhizae without mildew, moisturizes, and is sliced, adds water to cook 3 times, 2 hours every time, collecting decoction, standing overnight made to precipitate, and took
Supernatant is concentrated into paste, and measurement liquiritin content must not be less than 0 .5%, and glycyrrhizic acid must not be less than 7.0%, obtain Radix Glycyrrhizae
Medicinal extract, it is spare;
2) mix: by raw material obtained in step (1) first cross 60 meshes, then weigh respectively formula rate Rhizoma Gastrodiae extract,
Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root are sufficiently mixed uniformly.
The auxiliary material pharmaceutically received is added in composition described in the present embodiment can be prepared into granule.The present embodiment institute
The Rhizoma Gastrodiae composition stated has good application in prevention insomnia.
Embodiment 2
A kind of Rhizoma Gastrodiae composition being effectively improved sleep, the raw material including following parts by weight: 4 parts of Rhizoma Gastrodiae extract, semen ziziphi spinosae mentions
Take 16 parts of object, 13 parts of siberian Ginseng P.E, 8 parts of extract of licorice root.
A kind of preparation method for the Rhizoma Gastrodiae composition being effectively improved sleep, it is characterised in that the following steps are included:
1) raw material preparation: taking that meat is thick and solid, Gastrodia Elata Stem Tuber of no disease and pests harm, 55 DEG C low temperature drying 22 hours, crush, cross 8 meshes,
65% ethyl alcohol for adding 8 times of amounts is Extraction solvent, and heating and refluxing extraction 2 times, 0.5 hour every time, second was recovered under reduced pressure in combined extract
Alcohol is concentrated into and is equivalent to crude drug 0.4g/mL, and 4000r/min is centrifuged 10 minutes, takes supernatant, is concentrated under reduced pressure into and is equivalent to crude drug
3g/mL adds ethyl alcohol to alcohol content 65%, stands 22h, filtration, adds 35%NaOH solution tune pH value to 8.0, stands 22h, filtration,
Filtrate is concentrated under reduced pressure into paste in 45 DEG C and recycles ethyl alcohol, and 45 DEG C or less vacuum drying obtain Rhizoma Gastrodiae extract, spare;It takes
Semen ziziphi spinosae seed, is crushed into powder, and adding 55% ethyl alcohol of 7 times of amounts is Extraction solvent, heating and refluxing extraction 2 hours after impregnating 25 minutes,
Filtration;Add 55% ethyl alcohol of 5 times of amounts for Extraction solvent, heating and refluxing extraction 1 time, every time 1.5 hours;Filtration, combined extract,
Ethyl alcohol is recovered under reduced pressure, being concentrated into relative density is 1.22, adds ethyl alcohol to alcohol content 65%, stands 22h, filtration, filtrate is in 45 DEG C
It is concentrated under reduced pressure into paste and recycles ethyl alcohol, 45 DEG C or less vacuum drying obtain Wild jujube seeds extract, spare;Take Radix Acanthopanacis Senticosi root
Stem is cleaned out, and is crushed into powder, and adding 75% ethyl alcohol of 8 times of amounts is Extraction solvent, heating and refluxing extraction 2 hours, is filtered;Add 8 times
Amount 70% ethyl alcohol be Extraction solvent, heating and refluxing extraction 1 time, every time 1.5 hours;Second is recovered under reduced pressure in filtration, combined extract
Alcohol, being concentrated into relative density is 1.22, adds ethyl alcohol to alcohol content 65%, stands 22h, filtration, filtrate is concentrated under reduced pressure into 45 DEG C
Paste simultaneously recycles ethyl alcohol, and 45 DEG C or less vacuum drying obtain siberian Ginseng P.E, spare;Take matter heavily fortified point, taste pure, without mildew
Radix Glycyrrhizae moisturizes, and slice adds water to cook 2 times, 1.5 hours every time, collecting decoction, standing overnight made to precipitate, and supernatant is taken to be concentrated
To paste, 0 .5% must not be less than by measuring liquiritin content, and glycyrrhizic acid must not be less than 7.0%, obtain extract of licorice root, spare;
2) mix: by raw material obtained in step (1) first cross 60 meshes, then weigh respectively formula rate Rhizoma Gastrodiae extract,
Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root are sufficiently mixed uniformly.
The auxiliary material pharmaceutically received is added in composition described in the present embodiment can be prepared into pulvis.Described in the present embodiment
Rhizoma Gastrodiae composition on auxiliary treatment of insomnia disease have good application.
Embodiment 3
A kind of Rhizoma Gastrodiae composition being effectively improved sleep, the raw material including following parts by weight: 16 parts of Rhizoma Gastrodiae extract, semen ziziphi spinosae mentions
Take 33 parts of object, 33 parts of siberian Ginseng P.E, 25 parts of extract of licorice root.
A kind of preparation method for the Rhizoma Gastrodiae composition being effectively improved sleep, it is characterised in that the following steps are included:
1) raw material preparation: taking that meat is thick and solid, Gastrodia Elata Stem Tuber of no disease and pests harm, 65 DEG C low temperature drying 26 hours, crush, cross 12 mesh
Sieve, adding 75% ethyl alcohol of 12 times of amounts is Extraction solvent, and heating and refluxing extraction 4 times, 1.5 hours every time, combined extract depressurized back
Ethyl alcohol is received, is concentrated into and is equivalent to crude drug 0.6g/mL, 6000 r/min are centrifuged 20 minutes, take supernatant, are concentrated under reduced pressure into quite
In crude drug 5g/mL, adding ethyl alcohol to alcohol content 75%, stands 26h, filtration adds 45%NaOH solution tune pH value to stand 26h to 8.0,
Filtration, filtrate are concentrated under reduced pressure into paste in 55 DEG C and recycle ethyl alcohol, and 55 DEG C or less vacuum drying obtain Rhizoma Gastrodiae extract, standby
With;Semen ziziphi spinosae seed is taken, is crushed into powder, adding 65% ethyl alcohol of 9 times of amounts is Extraction solvent, heating and refluxing extraction 4 after impregnating 35 minutes
Hour, filtration;Add 65% ethyl alcohol of 7 times of amounts for Extraction solvent, heating and refluxing extraction 3 times, every time 2.5 hours;Filtration, merging mention
Take liquid, ethyl alcohol be recovered under reduced pressure, being concentrated into relative density is 1.24, adds ethyl alcohol to alcohol content 75%, stand 26h, filtration, filtrate in
55 DEG C are concentrated under reduced pressure into paste and recycle ethyl alcohol, and 55 DEG C or less vacuum drying obtain Wild jujube seeds extract, spare;Take thorn five
Add rhizome, clean out, be crushed into powder, adding 85% ethyl alcohol of 12 times of amounts is Extraction solvent, heating and refluxing extraction 4 hours, is filtered;
Add 80% ethyl alcohol of 12 times of amounts for Extraction solvent, heating and refluxing extraction 3 times, every time 2.5 hours;Filtration, combined extract, decompression
Ethyl alcohol is recycled, being concentrated into relative density is 1.24, adds ethyl alcohol to alcohol content 75%, stands 26h, filtration, filtrate is depressurized in 55 DEG C
It is concentrated into paste and recycles ethyl alcohol, 55 DEG C or less vacuum drying obtain siberian Ginseng P.E, spare;Take that matter is hard, taste is pure, nothing
The Radix Glycyrrhizae of mildew, moisturizes, and slice adds water to cook 4 times, 2.5 hours every time, collecting decoction, standing overnight made to precipitate, and took supernatant
Liquid is concentrated into paste, and measurement liquiritin content must not be less than 0 .5%, and glycyrrhizic acid must not be less than 7.0%, obtain extract of licorice root,
It is spare;
2) mix: by raw material obtained in step (1) first cross 60 meshes, then weigh respectively formula rate Rhizoma Gastrodiae extract,
Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root are sufficiently mixed uniformly.
The auxiliary material pharmaceutically received is added in composition described in the present embodiment can be prepared into liquid preparation.The present embodiment
The Rhizoma Gastrodiae composition has good application in prevention insomnia.
Embodiment 4
A kind of Rhizoma Gastrodiae composition being effectively improved sleep, the raw material including following parts by weight: 8 parts of Rhizoma Gastrodiae extract, semen ziziphi spinosae mentions
Take 25 parts of object, 13 parts of siberian Ginseng P.E, 8 parts of extract of licorice root, 10 parts of pregelatinized starch, 1.0 parts of croscarmellose sodium,
0.5 part of silica, 0.5 part of magnesium stearate.
A kind of preparation for the Rhizoma Gastrodiae composition being effectively improved sleep, the preparation are capsule.
The preparation method of capsule described in the present embodiment the following steps are included:
1) be sieved: taking that meat is thick and solid, Gastrodia Elata Stem Tuber of no disease and pests harm, 60 DEG C low temperature drying 24 hours, crush, cross 10 meshes, add
70% ethyl alcohol of 10 times of amounts is Extraction solvent, and heating and refluxing extraction 3 times, 1 hour every time, ethyl alcohol was recovered under reduced pressure in combined extract,
It is concentrated into and is equivalent to crude drug 0.5g/mL, 5000 r/min are centrifuged 15 minutes, are taken supernatant, are concentrated under reduced pressure into and are equivalent to crude drug 4g/
ML adds ethyl alcohol to alcohol content 70%, stands filtration for 24 hours, add 40%NaOH solution tune pH value to 8.0, stand filtration for 24 hours, filtrate
Paste is concentrated under reduced pressure into 50 DEG C and recycles ethyl alcohol, and 50 DEG C or less vacuum drying obtain Rhizoma Gastrodiae extract, spare;Take wild jujube
Benevolence seed, is crushed into powder, and adding 60% ethyl alcohol of 8 times of amounts is Extraction solvent, heating and refluxing extraction 3 hours after impregnating 30 minutes, filter
It crosses;Add 60% ethyl alcohol of 6 times of amounts for Extraction solvent, heating and refluxing extraction 2 times, every time 2 hours;Filtration, combined extract, decompression
Recycle ethyl alcohol, be concentrated into relative density for 1.21-1.23 between, add ethyl alcohol to alcohol content 70%, stand for 24 hours, filter, filtrate in
50 DEG C are concentrated under reduced pressure into paste and recycle ethyl alcohol, and 50 DEG C or less vacuum drying obtain Wild jujube seeds extract, spare;Take thorn five
Add rhizome, clean out, be crushed into powder, adding 80% ethyl alcohol of 10 times of amounts is Extraction solvent, heating and refluxing extraction 3 hours, is filtered;
Add 75% ethyl alcohol of 10 times of amounts for Extraction solvent, heating and refluxing extraction 2 times, every time 2 hours;Filtration, combined extract depressurize back
Receive ethyl alcohol, be concentrated into relative density for 1.21-1.23 between, add ethyl alcohol to alcohol content 70%, stand for 24 hours, filter, filtrate in
50 DEG C are concentrated under reduced pressure into paste and recycle ethyl alcohol, and 50 DEG C or less vacuum drying obtain siberian Ginseng P.E, spare;Take matter it is hard,
Taste is pure, Radix Glycyrrhizae without mildew, moisturizes, and is sliced, adds water to cook 3 times, 2 hours every time, collecting decoction, standing overnight made to precipitate, and took
Supernatant is concentrated into paste, and measurement liquiritin content must not be less than 0 .5%, and glycyrrhizic acid must not be less than 7.0%, obtain Radix Glycyrrhizae
Medicinal extract, it is spare;Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root are crossed into 60 meshes respectively, it is spare;
2) it weighs: weighing Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, pregelatinated by formula rate
Starch, croscarmellose sodium, silica, magnesium stearate are spare;
3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, pregelatinized starch, crosslinking
Sodium carboxymethylcellulose, silica mixing 25min, obtain mixed powder;
4) softwood processed: being added mixed powder softwood for 65% ethyl alcohol, and additional amount is that 65% ethyl alcohol 28ml is added in every 100g mixed powder, is mixed
Close uniformly, be allowed to hold it is agglomerating, gently pinch i.e. dissipate;
5) it pelletizes, dry, whole grain: the softwood made being pelletized by 16 meshes, then places 50 DEG C of dry 1.5h in baking oven, mistake
16 mesh sieves;
6) by particle and the magnesium stearate mixing 3min after whole grain, total hybrid particles total mix: are obtained;
7) capsule is filling: gained always being mixed granule filling, obtains capsule.
The filling specification of the capsule is 0.6g/, is filled in 0# capsule, and packing specification is 60/bottle, is used
Oral stable medicinal polythene bottle with high density is packed;The amount and eating method of the capsule are 2 times a day, often
Secondary 2, sooner or later each 1 time.
Embodiment 5
A kind of Rhizoma Gastrodiae composition being effectively improved sleep, the raw material including following parts by weight: 12 parts of Rhizoma Gastrodiae extract, semen ziziphi spinosae mentions
Take 28 parts of object, 16 parts of siberian Ginseng P.E, 10 parts of extract of licorice root, 30 parts of pregelatinized starch, croscarmellose sodium 5.0
Part .5 parts of silica 1,1.5 parts of magnesium stearate.
A kind of preparation for the Rhizoma Gastrodiae composition being effectively improved sleep, the preparation are capsule.
The preparation method of the capsule the following steps are included:
1) it is sieved: Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root is crossed into 60 meshes respectively, it is spare;
2) it weighs: weighing Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, pregelatinated by formula rate
Starch, croscarmellose sodium, silica, magnesium stearate are spare;
3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, pregelatinized starch, crosslinking
Sodium carboxymethylcellulose, silica mixing 35min, obtain mixed powder;
4) softwood processed: being added mixed powder softwood for 75% ethyl alcohol, and additional amount is that 75% ethyl alcohol 32ml is added in every 100g mixed powder, is mixed
Close uniformly, be allowed to hold it is agglomerating, gently pinch i.e. dissipate;
5) it pelletizes, dry, whole grain: the softwood made being pelletized by 20 meshes, then places 60 DEG C of dry 2.5h in baking oven, mistake
20 mesh sieves;
6) by particle and the magnesium stearate mixing 7min after whole grain, total hybrid particles total mix: are obtained;
7) capsule is filling: gained always being mixed granule filling, obtains capsule.
The filling specification of the capsule is 0.6g/, is filled in 0# capsule, and packing specification is 60/bottle, is used
Oral stable medicinal polythene bottle with high density is packed;The amount and eating method of the capsule are 2 times a day, often
Secondary 2, sooner or later each 1 time.
Embodiment 6
A kind of Rhizoma Gastrodiae composition being effectively improved sleep, the raw material including following parts by weight: 14 parts of Rhizoma Gastrodiae extract, semen ziziphi spinosae mentions
Take 30 parts of object, 20 parts of siberian Ginseng P.E, 12 parts of extract of licorice root, 20 parts of pregelatinized starch, croscarmellose sodium 3.0
Part, silica 1 part, 1 part of magnesium stearate.
A kind of preparation for the Rhizoma Gastrodiae composition being effectively improved sleep, the preparation are capsule.
The preparation method of the capsule the following steps are included:
1) it is sieved: Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root is crossed into 60 meshes respectively, it is spare;
2) it weighs: weighing Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, pregelatinated by formula rate
Starch, croscarmellose sodium, silica, magnesium stearate are spare;
3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, pregelatinized starch, crosslinking
Sodium carboxymethylcellulose, silica mixing 30min, obtain mixed powder;
4) softwood processed: being added mixed powder softwood for 70% ethyl alcohol, and additional amount is that 70% ethyl alcohol 30ml is added in every 100g mixed powder, is mixed
Close uniformly, be allowed to hold it is agglomerating, gently pinch i.e. dissipate;
5) it pelletizes, dry, whole grain: the softwood made being pelletized by 18 meshes, 18 DEG C of dry 2h in baking oven is then placed, crosses 18
Mesh sieve;
6) by particle and the magnesium stearate mixing 5min after whole grain, total hybrid particles total mix: are obtained;
7) capsule is filling: gained always being mixed granule filling, obtains capsule.
The filling specification of the capsule is 0.6g/, is filled in 0# capsule, and packing specification is 60/bottle, is used
Oral stable medicinal polythene bottle with high density is packed;The amount and eating method of the capsule are 2 times a day, often
Secondary 2, sooner or later each 1 time.
Embodiment 7
A kind of Rhizoma Gastrodiae composition being effectively improved sleep, the raw material including following parts by weight: 9 parts of Rhizoma Gastrodiae extract, semen ziziphi spinosae mentions
Take 26 parts of object, 15 parts of siberian Ginseng P.E, 9 parts of extract of licorice root, 32 parts of microcrystalline cellulose, 2.0 parts of croscarmellose sodium,
6.0 parts of silica, 6.0 parts of magnesium stearate, 2.5 parts of coating powder.
A kind of preparation for the Rhizoma Gastrodiae composition being effectively improved sleep, the preparation are tablet.
The preparation method of the tablet the following steps are included:
1) be sieved: taking that meat is thick and solid, Gastrodia Elata Stem Tuber of no disease and pests harm, 61 DEG C low temperature drying 24 hours, crush, cross 10 meshes, add
71% ethyl alcohol of 11 times of amounts is Extraction solvent, and heating and refluxing extraction 3 times, 1.2 hours every time, second was recovered under reduced pressure in combined extract
Alcohol is concentrated into and is equivalent to crude drug 0.5g/mL, and 5500 r/min are centrifuged 16 minutes, takes supernatant, is concentrated under reduced pressure into and is equivalent to crude drug
4g/mL adds ethyl alcohol to alcohol content 71%, stands filtration for 24 hours, adds 41%NaOH solution tune pH value to 8.0, stands 23h, filtration,
Filtrate is concentrated under reduced pressure into paste in 52 DEG C and recycles ethyl alcohol, and 52 DEG C or less vacuum drying obtain Rhizoma Gastrodiae extract, spare;It takes
Semen ziziphi spinosae seed, is crushed into powder, and adding 61% ethyl alcohol of 8 times of amounts is Extraction solvent, heating and refluxing extraction 3 hours after impregnating 31 minutes,
Filtration;Add 61% ethyl alcohol of 6 times of amounts for Extraction solvent, heating and refluxing extraction 2 times, every time 2.1 hours;Filtration, combined extract,
Ethyl alcohol is recovered under reduced pressure, being concentrated into relative density is 1.22, adds ethyl alcohol to alcohol content 71%, stands 23h, filtration, filtrate is in 51 DEG C
It is concentrated under reduced pressure into paste and recycles ethyl alcohol, 51 DEG C or less vacuum drying obtain Wild jujube seeds extract, spare;Take Radix Acanthopanacis Senticosi root
Stem is cleaned out, and is crushed into powder, and adding 81% ethyl alcohol of 11 times of amounts is Extraction solvent, heating and refluxing extraction 3 hours, is filtered;Add 11
Times amount 75% ethyl alcohol be Extraction solvent, heating and refluxing extraction 2 times, every time 2 hours;Second is recovered under reduced pressure in filtration, combined extract
Alcohol, being concentrated into relative density is 1.22, adds ethyl alcohol to alcohol content 70%, stands 25h, filtration, filtrate is concentrated under reduced pressure into 51 DEG C
Paste simultaneously recycles ethyl alcohol, and 51 DEG C or less vacuum drying obtain siberian Ginseng P.E, spare;Take matter heavily fortified point, taste pure, without mildew
Radix Glycyrrhizae moisturizes, and slice adds water to cook 3 times, 2.2 hours every time, collecting decoction, standing overnight made to precipitate, and supernatant is taken to be concentrated
To paste, 0 .5% must not be less than by measuring liquiritin content, and glycyrrhizic acid must not be less than 7.0%, obtain extract of licorice root, spare;
Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root cross 60 meshes respectively, spare;
2) weigh: it is fine to weigh Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, crystallite by formula rate
It is spare to tie up element, croscarmellose sodium, silica, magnesium stearate, coating powder;
3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, microcrystalline cellulose, crosslinking
Sodium carboxymethylcellulose, silica mixing 25min, obtain mixed powder;
4) softwood processed: being added mixed powder softwood for 65% ethyl alcohol, and additional amount is that 65% ethyl alcohol 28ml is added in every 100g mixed powder, is made
Hold it is agglomerating, gently pinch i.e. dissipate;
5) it pelletizes, dry, whole grain: the softwood made being pelletized by 16 meshes, then places 50 DEG C of dry 2.5h in baking oven, mistake
20 mesh sieves;
6) by particle and the magnesium stearate mixing 3min after whole grain, total hybrid particles total mix: are obtained;
7) granulation will always tabletting, coating, bottling: be mixed;Then coating powder is configured to 8% coating solution with 65% ethyl alcohol, it is right
Tabletting is coated, coating weight gain 2%, bottling.
Further, the tabletting specification of the tablet is 0.6g/ piece, and the bottling is using the medicinal height of oral administration solid
Density polyethylene bottle carries out, and bottling specification is 80 pieces/bottle;The amount and eating method of the tablet: 2 times a day, every time 2
Piece, each 1 time sooner or later.
Embodiment 8
A kind of Rhizoma Gastrodiae composition being effectively improved sleep, the raw material including following parts by weight: 13 parts of Rhizoma Gastrodiae extract, semen ziziphi spinosae mentions
Take 31 parts of object, 19 parts of siberian Ginseng P.E, 11 parts of extract of licorice root, 38 parts of microcrystalline cellulose, croscarmellose sodium 3.0
Part, 0 part of silica 1,10 parts of magnesium stearate, 3.5 parts of coating powder.
A kind of preparation for the Rhizoma Gastrodiae composition being effectively improved sleep, the preparation are tablet.
The preparation method of the tablet the following steps are included:
1) it is sieved: Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root being taken to cross 60 meshes respectively, it is spare;
2) weigh: it is fine to weigh Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, crystallite by formula rate
It is spare to tie up element, croscarmellose sodium, silica, magnesium stearate, coating powder;
3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, microcrystalline cellulose, crosslinking
Sodium carboxymethylcellulose, silica mixing 35min, obtain mixed powder;
4) softwood processed: being added mixed powder softwood for 75% ethyl alcohol, and additional amount is that 75% ethyl alcohol 32ml is added in every 100g mixed powder, is made
Hold it is agglomerating, gently pinch i.e. dissipate;
5) it pelletizes, dry, whole grain: the softwood made being pelletized by 20 meshes, then places 60 DEG C of dry 2.5h in baking oven, mistake
20 mesh sieves;
6) by particle and the magnesium stearate mixing 7min after whole grain, total hybrid particles total mix: are obtained;
7) granulation will always tabletting, coating, bottling: be mixed;Then coating powder is configured to 12% coating solution with 75% ethyl alcohol, it is right
Tabletting is coated, coating weight gain 4%, bottling.
Further, the tabletting specification of the tablet is 0.6g/ piece, and the bottling is using the medicinal height of oral administration solid
Density polyethylene bottle carries out, and bottling specification is 80 pieces/bottle;The amount and eating method of the tablet: 2 times a day, every time 2
Piece, each 1 time sooner or later.
Embodiment 9
A kind of Rhizoma Gastrodiae composition being effectively improved sleep, the raw material including following parts by weight: 15 parts of Rhizoma Gastrodiae extract, semen ziziphi spinosae mentions
Take 32 parts of object, 24 parts of siberian Ginseng P.E, 15 parts of extract of licorice root, 35 parts of microcrystalline cellulose, croscarmellose sodium 2.5
Part, 8 parts of silica, 8 parts of magnesium stearate, 3.0 parts of coating powder.
A kind of preparation for the Rhizoma Gastrodiae composition being effectively improved sleep, the preparation are tablet.
The preparation method of the tablet the following steps are included:
1) it is sieved: Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root being taken to cross 60 meshes respectively, it is spare;
2) weigh: it is fine to weigh Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, crystallite by formula rate
It is spare to tie up element, croscarmellose sodium, silica, magnesium stearate, coating powder;
3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, microcrystalline cellulose, crosslinking
Sodium carboxymethylcellulose, silica mixing 30min, obtain mixed powder;
4) softwood processed: being added mixed powder softwood for 70% ethyl alcohol, and additional amount is that 70% ethyl alcohol 30ml is added in every 100g mixed powder, is made
Hold it is agglomerating, gently pinch i.e. dissipate;
5) it pelletizes, dry, whole grain: the softwood made being pelletized by 18 meshes, 55 DEG C of dry 2h in baking oven is then placed, crosses 18
Mesh sieve;
6) by particle and the magnesium stearate mixing 5min after whole grain, total hybrid particles total mix: are obtained;
7) granulation will always tabletting, coating, bottling: be mixed;Then coating powder is configured to 10% coating solution with 70% ethyl alcohol, it is right
Tabletting is coated, coating weight gain 3%, bottling.
Further, the tabletting specification of the tablet is 0.6g/ piece, and the bottling is using the medicinal height of oral administration solid
Density polyethylene bottle carries out, and bottling specification is 80 pieces/bottle;The amount and eating method of the tablet: 2 times a day, every time 2
Piece, each 1 time sooner or later.
Embodiment 10
A kind of Rhizoma Gastrodiae composition being effectively improved sleep, capsule agent prescription (by mass percentage):
Rhizoma Gastrodiae extract 8%, Wild jujube seeds extract 30%, siberian Ginseng P.E 17%, extract of licorice root 12%, pregelatinized starch 27.5%,
Croscarmellose sodium 4%, silica 0.7%, magnesium stearate 0.8%.
Two, production technology:
(1) be sieved: the supplementary materials such as Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root cross 60 mesh respectively
Sieve;
(2) it weighs: according to product formula, the inventory of each supplementary material is calculated according to output, then weighs Rhizoma Gastrodiae extract, acid
Jujube kernel extract, siberian Ginseng P.E, extract of licorice root, pregelatinized starch, croscarmellose sodium, silica, tristearin
Sour magnesium is spare.
(3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, cross-linked carboxymethyl
Sodium cellulosate, silica mix about 30min, obtain mixed powder, spare.
(4) softwood processed: being added mixed powder softwood for 70% ethyl alcohol, and 70% ethyl alcohol is added about according to every 100g mixed powder
30ml, be allowed to hold it is agglomerating, gently pinch i.e. dissipate.
(5) it pelletizes, dry, whole grain: the softwood made being pelletized by 18 meshes, then places 55 DEG C of left and right trunks in baking oven
Dry about 2h crosses 18 mesh sieves.
(6) by particle and the magnesium stearate mixing 5min after whole grain, total hybrid particles total mix: are obtained.
(7) capsule is filling: gained hybrid particles are dispensed into 0# capsule using automatic filling machine for capsules is filling, 0.6g/.
(8) it bottles: using oral stable medicinal polythene bottle with high density, packing specification is 60/bottle.
(9) outer packing: select standard compliant carton (quality standard is GB/T 6543) as housing material, packaging
It in the process should packaging quality check at any time.
Three, amount and eating method: 2 times a day, 2 tablets each time, each 1 time sooner or later.
Embodiment 11
One, a kind of Rhizoma Gastrodiae composition for being effectively improved sleep, tablet formula (press mass parts):
8 parts of Rhizoma Gastrodiae extract, 30 parts of Wild jujube seeds extract, 17 parts of siberian Ginseng P.E, 12 parts of extract of licorice root, microcrystalline cellulose
32.5 parts, 2 parts of croscarmellose sodium, 8 parts of silica, 7 parts of magnesium stearate, 2.5 parts of coating powder.
Two, production technology:
(1) be sieved: the supplementary materials such as Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root cross 60 mesh respectively
Sieve;
(2) it weighs: according to product formula, the inventory of each supplementary material is calculated according to output, then weighs Rhizoma Gastrodiae extract, acid
Jujube kernel extract, siberian Ginseng P.E, extract of licorice root, microcrystalline cellulose, croscarmellose sodium, silica, tristearin
Sour magnesium, coating powder are spare.
(3) mix: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, microcrystalline cellulose,
Croscarmellose sodium, silica mix about 30min, obtain mixed powder, spare.
(4) softwood processed: being added mixed powder softwood for 70% ethyl alcohol, and 70% ethyl alcohol is added about according to every 100g mixed powder
30ml, be allowed to hold it is agglomerating, gently pinch i.e. dissipate.
(5) it pelletizes, dry, whole grain: the softwood made being pelletized by 18 meshes, then places 55 DEG C of left and right trunks in baking oven
Dry about 2h crosses 18 mesh sieves.
(6) by particle and the magnesium stearate mixing 5min after whole grain, total hybrid particles total mix: are obtained.
(7) granulation, 0.6g/ piece will always tabletting, coating: be mixed.Coating powder is configured to 10% coating with 70% ethyl alcohol
Liquid coating, coating weight gain 3%.
(8) it bottles: using oral stable medicinal polythene bottle with high density, packing specification is 80 pieces/bottle.
(9) outer packing: select standard compliant carton (quality standard is GB/T 6543) as housing material, packaging
It in the process should packaging quality check at any time.
Three, amount and eating method: 2 times a day, 2 tablets once, and each 1 time sooner or later.
Test example 1 --- animal experiment
Rhizoma Gastrodiae composition in the embodiment of the present invention 9 is tested by animal efficacy assessments, as the result is shown: the composition 1.2g/
Kg.bw/d test group mouse yellow Jackets sleeping time is longer than 0g/kg.bw/d control group;0.4g/kg.bw/d and 1.2g/
Kg.bw/d test group mouse barbital sodium Sleep latency is shorter than 0g/kg.bw/d control group.The composition to known to has
It is significant to improve sleep function.
It is tested by animal toxicology, as the result is shown: the composition acute toxicity dosage is determined as nontoxic;Give rat people
100 times of body recommended dose are fed for 30 days, do not observe toxic effect;The test of animal deformity is feminine gender.
Test portion:
One, toxicological test
(1) acute oral toxicity test
1 material and method
1.1 experimental animals: SPF grades of healthy adult ICR mouse 20, half male and half female, the weight of animals female are 18.4-21.1g,
Male is 19.5-21.8g, is provided by Nanjing Medical University's pharmaceutical experiment animal center, production licence number SCXK(Soviet Union) 2016-
0002, quality certification number: 201720235.
The selection of 1.2 dosage gives mode with tested material: carrying out acute toxicity test in mice with maximal tolerance dose method, designs
Dosage is 15000mg/kg.bw.Test preceding animal fasting 16 hours, free water.Given the test agent is crushed into powder using pulverizer
End, and prepared using sterile water, maximum dose concentration is 750mg/mL, by maximum stomach-filling amount (20mL/kg.bw), sample is once given,
Tested material gives dosage 15000mg/kg.bw.To being observed continuously after sample 14 days, poisoning manifestations and death condition are recorded.
1.3 test methods: acute toxicity test in mice is carried out with maximal tolerance dose method.
2. result
During experimental observation, groups of animals diet and activity are normal, well-grown, have no any poisoning manifestations and death.Combination
Influence of the object to mouse and death toll is shown in Table 1.
Influence of 1 composition of table to mouse and death toll
3 brief summaries
Obvious poisoning manifestations are had no after this composition of orally administration animal, the weight of animals growth are had no significant effect, in the observation period
Without animal dead.This composition is female, male mice acute oral MTD is greater than 15000mg/kgbw, according to acute toxicity dosage point
Grade standard, the sample belong to nontoxic grade.
Feeding trial report in (two) 30 days
1 material and method
1.1 experimental animals: SPF grades of healthy height cream SD rat 80, half male and half female are had by the western Poole-Bi Kai experimental animal in Shanghai
Limit company provides, the Shanghai production licence number SCXK() 2013-0016, quality certification number: 2008001684028.Animal purchase
Afterwards, it quarantines 3 days, junctor is randomly divided into control group, low dose group, middle dose group, 4 groups of high dose group again, every group 20, male, male
It is fifty-fifty.Heap animal original body mass is 71~81g;Buck original body mass is 80~92g.
1.2 dosage select to give mode with tested material: composition tablet human body recommended dose is 2.4g/ people/day, with 60kg
Weight calculates, and sets 1.2 g/kg.bw/d, 2.6g/kg.bw/d, 4.0 g/ by the 30 of human body recommended dose, 65 and 100 times
Tri- dosage groups of kg.bw/d, separately set a blank control group 0gkg.b/wd.Given the test agent is ground into powder using pulverizer, so
Afterwards by rat is fed in diluted method incorporation basal feed step by step, when given the test agent mixes feed, converted by the 10% of weight,
The percentage composition that low dose group given the test agent mixes basal feed is 1.2%, and middle dose group given the test agent mixes the hundred of basestocks
Dividing content is 2.6%, and the percentage composition that high dose group given the test agent mixes basal feed is 4.0%.Control group is basic feed.
It is continuous to feed 30 days.Animal ad lib drinking-water.
1.3 test method
Groups of animals gave the continuous feeding of each dosage group feed after 30 days, fasting overnight, by only weighing, 10% chloraldurate abdominal cavity
Injecting anesthetic surveys its hematological indices and blood parameters through abdominal aortic blood.
1.3.1 ordinary circumstance is observed: observing and recording general performance, behavior, poisoning manifestations and the dead feelings of animal daily
Condition.
1.3.2 weight, food utilization: claiming weekly 1 weight and 2 food intake doses, calculates food weekly and always
Utilization rate.
1.3.3 hematological indices: rat blood is taken to measure its blood red egg with SIEMENS ADVIA2120i blood analyser
Bai Hanliang, red blood cell count(RBC), from cell count and its classification etc..
1.3.4 blood parameters: taking rat blood serum, measures serum paddy third with 7100 type automatic clinical chemistry analyzer of Hitachi
Transaminase, glutamic-oxalacetic transaminease, total protein, albumin, total cholesterol, urea nitrogen, creatinine, blood glucose, triglycerides etc..
1.3.5 organ coefficient: after carrying out gross anatomy inspection Check, careful separation liver, kidney, spleen, testis, ovary are used
Physiological saline is cleaned, and is weighed after filter paper water suction, is calculated separately liver, kidney, spleen, testis, ovary relative weight (dirty/body).
1.3.6 pathology are examined: control group and high dose group rat liver, spleen, Stomach duodenum, testis, ovary being taken to use
Formaldehyde is fixed, paraffin embedding, slice, carries out histopathological examination after HE dyeing.
1.3.7 test data counts: carrying out homogeneity of variance inspection to each experiment initial data with SPSS software
It tests, meets the data information test groups multiple in one-way analysis of variance method that variance requires together
The comparative approach two-by-two of mean carries out statistical disposition between a control group;To the number of heterogeneity of variance
Statistical disposition is carried out using rank sum test according to data.
2. result
2.1 design dose lonvestions are at actual dose
The dosage set by 30 times, 65 times, 100 times of human body recommended dose 24g/ people/day (weight is based on 60kg) is respectively
1.2 g/kg.bw/d, 2.6 g/kg.bw/d, 4.0 g/kg.bw/d(are basic, normal, high), it is equivalent to 33 times of human body recommended amounts, 73
Again, 115 times, male is that 1.33g/kg.bw/d, 2.83g/kgbw/d, 4.47g/kgbw/d(are basic, normal, high), it is equivalent to people
33 times, 71 times, 112 times of body recommended amounts.
1 dose lonvestion situation of table ()
2.2 overviews: the general appearance and behavior of groups of animals are showed no obvious abnormalities, without poisoning manifestations, without death.
Influence of the composition to rat body weight
As can be seen from Table 2, female male group the 0th day each dosage group of weight of rat is compared with 0g/kgbw/d group, no statistical difference is anticipated
Justice (P> 0.05) weight of rat is more balanced between each group before, testing.
Orally administration rat various dose 30 days carries out homogeneity of variance inspection to the rat body weight of each point of observation of each dosage group
It tests, each index is all satisfied variance requirement, with mean between test groups multiple in one-way analysis of variance method and a control group
Comparative approach carries out statistical disposition two-by-two.By 2 result of table as it can be seen that the weight and 0g/ of each point of observation of each dosage group of female male rat
Kgbw/d group compares, difference it is not statistically significant (P> 0.05).
2 composition of table to rat body weight influence ()
Influence of 2.4 compositions to rat chow utilization rate
The composition of orally administration rat various dose 30 days, table 3 are the weight gain of each group rat, and table 4 is each group rat food ration, table
5 be each group rat chow utilization rate, and indices carry out homogeneity test of variance, and the 1st week food ration of female rats is eaten on the the 1st, 3 week
Object utilization rate is unsatisfactory for homogeneity of variance requirement, carries out statistical disposition with rank sum test, and other each indexs meet homogeneity of variance requirement,
With test groups multiple in one-way analysis of variance method between a control group mean two-by-two compared with carry out statistical disposition.As a result
As it can be seen that each index of each dosage is compared with 0g/kgbw/d group, difference it is not statistically significant (P> 0.05).
3 composition each group rat of table weight gain ()
4 composition each group rat of table food ration ()
Influence of 2.5 compositions to rat blood index
The composition of orally administration rat various dose 30 days measures each dosage group rat blood red blood cell count(RBC), hemoglobin
The indexs such as horizontal, white blood cell count(WBC) and its classification.Indices carry out homogeneity test of variance, female rats white blood cell count
It is unsatisfactory for variance to require together, carries out statistical disposition with rank sum test, other each indexs are all satisfied variance and require together, with single factor test side
Mean between multiple test groups and a control group in poor analysis method;Compare carry out statistical disposition two-by-two.It is by table 6 as it can be seen that each
Each index of dosage group compared with 0g/kgbw/d group, difference it is not statistically significant (P> 0.05).
5 composition each group rat of table food utilization ()
The hematological indices of 6 composition each group rat of table influence ()
Influence of 2.6 compositions to rat blood biochemical indicator
The composition of orally administration rat various dose 30 days measures each dosage group rat blood serum glutamic-pyruvic transaminase, millet straw turns ammonia
The level of enzyme, total protein, albumin, total cholesterol, triglycerides, urea nitrogen, creatinine and blood glucose.It is neat that indices carry out variance
Property examine, female rats serum blood glucose, urea nitrogen levels, male rat serum urea nitrogen, total cholesterol level are unsatisfactory for variance
It is neat to require, statistical disposition is carried out with rank sum test, other each indexs are all satisfied variance and require together, with one-way analysis of variance method
In between multiple test groups and a control group mean comparative approach two-by-two carry out statistical disposition.By table 7 as it can be seen that 4.0g/kg
Though bw/d group male rat serum creatinine level has statistical difference compared with 0 g/kgbw/d group, numerical value is in normal value
In range, and without dose-response relationship, it is not considered as that there is bad biological significance;Each index and 0g/ of other each dosage groups
Kgbw/d group compares, difference it is not statistically significant (P>0.05)。
The hematological indices of 6 composition each group rat of continued influence ()
7 composition of table to blood biochemistry of rats influence ()
2.7 general pathologies and histological examination
2.7.1 influence of the composition to Rats Organs and Tissues absolute weight and relative weight
The composition of orally administration rat various dose 30 days, measurement each group rat liver, kidney, board be dirty, testis, ovary are absolute
Weight and relative weight (dirty body).Indices carry out homogeneity test of variance, rat ovary relative weight, male rat spleen
Dirty absolute weight is unsatisfactory for variance with relative weight, kidney relative weight and requires together, carries out statistical disposition with rank sum test, other
Each index is all satisfied variance and requires together, with two of mean between test groups multiple in one-way analysis of variance method and a control group
Two comparative approach carry out statistical disposition.By table 8 as it can be seen that each index of each dosage group is compared with 0g/kgbw/d group, the equal nothing of difference
Statistical significance (P>0.05)。
7 composition of continued to blood biochemistry of rats influence ()
Note: * indicate compared with 0 g/kgbw/d group,P<0.05。
8 composition of table Rats Organs and Tissues absolute weight and relative weight are influenced ()
2.7.2 pathological examination
Each dosage group male and female rat gross anatomy observation is showed no abnormal change.
Microscopic examination result is as follows: 0 g/kgbw/d group female rats totally 10:
Liver: lobuli hepatis structure is clear, liver rope marshalling;The almost the same nucleus size of liver cell size is uniform, nuclear membrane, core
Benevolence understands, cytoplasm even dyeing.Slight hepatic cell steatosis 2 around portal area.
8 composition of table Rats Organs and Tissues absolute weight and relative weight are influenced ()
Kidney: kidney skin, medullary substance boundary clear, nephron structure is normal, and glomerulus is without inflammatory change, fibrosis, hyaloid lesion
Deng variation, renal tubule also has no obvious lesion.Renal tubule mild swelling 2.
Spleen: red, white pulp understands that central artery occupies acini lienalis center, and corpusculum is not expanded without obvious atrophy, board sinus, spleen
Girder is normal.
Stomach, 12 refer to: surface mucosa is normal, and no inflammatory changes and rotten to the corn, ulcer is formed.Under mucous membrane, muscle layer, placenta percreta it is equal
No inflammatory changes.
Ovary: the corpus luteum or lean type formed after the ovarian follicle of visible different developmental phases and ovulation in ovary.
0g/ kgbw/d group male rat totally 10:
Liver: lobuli hepatis structure is clear, liver rope marshalling;Liver cell size is almost the same, and nucleus size is uniform, nuclear membrane,
Kernel understands, cytoplasm even dyeing.Kidney victory: kidney skin, medullary substance boundary clear, nephron structure is normal, and glomerulus changes without inflammatory
The variation such as change, fibrosis, hyaloid lesion, renal tubule also have no obvious lesion.Board is dirty: red, white pulp understands that central artery occupies
Acini lienalis center, corpusculum are not expanded without obvious atrophy, snius lienis, and spleen trabeculae is normal.Stomach duodenum: surface mucosa is normal, no inflammation
It sexually revises and rotten to the corn, ulcer is formed under mucous membrane, muscle layer, placenta percreta change without inflammatory.Testis: convoluted tubule of testis is thin by supporting
Born of the same parents and epithelial cell, primary, secondary spermatocyte are constituted, and germ cell development is normal.
4.0g/ kgbw/d group female rats totally 10:
Liver: lobuli hepatis structure is clear, liver rope marshalling;Liver cell size is almost the same, and nucleus size is uniform, nuclear membrane,
Kernel understands, cytoplasm even dyeing.Around portal area and lobuli hepatis peripheral band slight hepatic cell steatosis 1, lobuli hepatis
Peripheral band slight hepatic cell steatosis 2.
Kidney: kidney skin, medullary substance boundary clear, nephron structure is normal, and glomerulus is without inflammatory change, fibrosis, hyaloid
The variation such as lesion, renal tubule also have no obvious lesion.Renal tubule mild swelling 1.
Spleen: red, white pulp understands, central artery occupies acini lienalis center, and corpusculum is without obviously withering
Two, animal teratogenesis is tested
1 material and method
1.1 samples: given the test agent is ground into powder, Salmonella reversion test, micronucleus test and mouse inbred strain using pulverizer
Tested using smashed powder.
Experimental animal: micronucleus test selects the cleaning grade ICR healthy mice of Yangzhou University's comparative medicine center's breeding, production
Credit number SCXK (Soviet Union) 2017-0007, quality certification number: 201726797;Mouse inbred strain selects Yangzhou University's ratio
Compared with the cleaning grade ICR healthy mice of medical center breeding, production licence number SCXK (Soviet Union) 2017-0007, the quality certification is numbered:
201726797。
Test method
1.3.1 Salmonella reversion test
Using dressing plate incorporation methods, salmonella typhimurium saltant TA97, TA98, TA100, TA102 are selected, it is identified
It is tested after qualification.Activation system is that rats'liver S-9, the 8-9 protein content that β-Cai's flavones and sodium phenobarbital induce is
30mg/mL, vigor have good metabolic activation ability to 2- aminofluorene.Add 10mL S-9 in every 100mL S-9 mixed liquor.Sun
Property object: it is 2,4,7- trinitrofluorenones (TA97, TA98) that S-9 person, which is not added, and methyl methylsulfonate (TA100, TA102) adds S-9 person
For 2- aminofluorene (TA97, TA98, TA100), 1,8- dihydroxy-anthracene matches (TA102), while setting negative control group (untreated control
Group and solvent control group).In the case where adding and S-9 mixed liquor being not added with the progress of 5000,1000,200,40 and 8ug/ ware dosage
Test, each dosage group make 3 plates.Sample is placed in high-temperature sterilization 20min under the conditions of 0.103Mpa, aseptically, claims
Amount given the test agent is simultaneously configured to solution, and given the test agent is configured to 50mg/mL, i.e. high dose group with DMSO, with DMSO by certain times
10,2,4 0.4,0.08mg/mL dosage groups are configured to than diluting step by step, sample-adding amount is 0.lmL/ ware.In 2mL top agar
Middle addition 0.1mL test strain enrichment liquid, 0.1mL given the test agent solution and 0.5mLS-9 mixed liquor are (when needing metabolism activation
When).It is poured into after mixing on bottom culture medium flat plate, 37 DEG C are cultivated 48 hours, are counted every ware and are returned change clump count.If given the test agent
The change clump count that returns of group is that negative control group returns change clump count 2 times or more, and it is then positive for having dose-response relationship.Entirely
Test repeats to do under the same conditions primary.
1.3.2 mouse marrow cell micro nuclear test
25 ~ 30g of weight cleaning grade ICR kind mouse 50 are selected, adapts to be tested for environment 5 days after animal purchase.By weight with
Machine is divided into 5 groups, and every group 10, half male and half female.Composition human body recommended intake are as follows: (weight presses 60kg to 2.4g/ people/day
Meter), 100 times of given the test agent human body recommended intake are as follows: 4000g/kgbw, therefore maximum dose level is set as 10000g/kgbw,
If 2500,5000,3 dosage groups of 1000mg/kgbw, negative control group (sterile water, 20mL/kgbw stomach-filling), positive right
According to group (cyclophosphamide, 40mg/kgbw intraperitoneal injection).Select sterile water as solvent according to the dissolubility of sample.Test sample
Product are prepared with sterile water, and it is 125,250,500mg/mL that low, middle and high dose groups contain given the test agent concentration respectively, with 20mL/kg
Bw stomach-filling gives tested material method using 30h.Twice for 24 hours to given the test agent interval, it is moved to execution in 6 hours after given the test agent for second
Object takes the film-making of breastbone routine, microscopy, and every mouse counts 1000 Polychromatic erythrocytes (PCE), observes the thermophilic polychromatophilia containing micronucleus
Red blood cell number simultaneously calculates microkernel incidence, in terms of permillage, is as a result examined using U and carries out statistical disposition.Every mouse counting 200 thermophilic
Observed mature erythrocyte number (NCE) when Polychromatic erythrocytes, and calculate polychromatic erythrocyte and mature erythrocyte ratio (
PCE/NCE)。
1.3.3 mouse inbred strain
25 ~ 35 cleaning grade ICR sexal maturity of weight male mice 25 is selected, adapts to be tested for environment 5 days after animal purchase.It presses
Weight is randomly divided into 5 groups, every group 5.Composition human body recommended intake are as follows: 2.4g/ people/day (weight is based on 60kg), it is tested
100 times of sample human body recommended intake are as follows: 4000g/kgbw, therefore maximum dose level is set as 1000g/kgbw, if 2500,
5000,10000g/kgbw3 dosage group, negative control group (sterile water, 20mL/kgbw stomach-filling), positive controls (ring
Phosphamide, 40mg/kgbw intraperitoneal injection).Select sterile water as solvent according to the dissolubility of sample.Given the test agent is with sterile
Water is prepared, and it is 125,250,500mg/mL that low, middle and high dose groups contain given the test agent concentration respectively, with 20mL/kgbw stomach-filling,
1 time a day, continuous 5d.The 35th day execution animal after giving given the test agent for the first time, takes two sides epididymal sperm filtrate routinely to make
Piece, microscopy.Every mouse counts the sperm of 100 structural integrities, calculates Sperm malformation rate (with percentage), as a result uses sum of ranks
It examines and carries out statistical disposition.
1.4 test datas statistics: micronucleus test result is examined using U and carries out statistical disposition, mouse inbred strain knot
Fruit carries out statistical disposition using rank sum test.
As a result
2.1Ames test
2.1.1 sterile test result: given the test agent solution, solvent control, buffer and S-9 mixture in aseptic flat board
Contaminated bacterium colony is not observed.
2.1.2Ames test result: by table 1, table 2 as it can be seen that each dosage group of composition returns and becomes clump count and be less than feminine gender
Control group returns 2 times of change clump count, also without dose-response relationship.I.e. composition to salmonella typhimurium TA97, TA98,
Tetra- plants of test strains of TA100, TA102 are showed no when adding and S-9 being not added and cause gene mutation effect.
1 composition Salmonella reversion test of table time change clump count () (first time)
Note: * * is more than negative control group bacterium colony 2 times or more.
2.2 mouse marrow cell micro nuclear test
Seen from table 3, there was no significant difference compared with negative control group (P > 0.05) for each dosage group micronuclear rates of composition, and positive
Property control group be higher than negative control group, have significant difference (P < 0.05).The PCE/NCE ratio of each dosage group of tested material with it is right
According to group difference within control group 20%, tested material does not have inhibiting effect to proliferation of bone marrow cells.Have no composition to mouse
Micronucleus is formed and polychromatic erythrocyte has an impact with mature erythrocyte ratio (PCE/NCE).
2 composition Salmonella reversion test of table time change clump count () (for the second time)
Note: * * is more than negative control group bacterium colony 2 times or more.
3 composition of table is to mouse Bone marrow cells micronucleus incidence and polychromatic erythrocyte and mature erythrocyte ratio (PCE/
NCE influence)
Note: * * compared with negative control group,p< 0.05。
Influence of 4 composition of table to mouse sperm deformity rate
Note: * * compared with negative control group,p< 0.05。
Mouse inbred strain
By table 4, table 5 as it can be seen that each dosage group rate of teratosperm is compared with negative control group, there was no significant difference (P < 0.05), and
Positive controls mouse sperm deformity rate is higher than negative control group, there is significant difference (P < 0.05).Therefore magnificent human relations board cordate telosma
Mouse sperm deformity rate is not had an impact.
Influence of 5 composition of table to mouse sperm deformity type and ratio
3 brief summaries
3.1 composition Salmonella reversion test results are feminine gender;
3.2 composition mouse marrow cell micro nuclear test results are feminine gender;
3.3 composition mouse inbred strain results are feminine gender.
Three, improve sleep function (animal experiment)
1 material and method
1.1 samples: given the test agent human body recommended dose is 24g/ people/day.
Experimental animal: select the SPF grade CL/F1 of the western Poole Bi Kai experimental animal Co., Ltd breeding in Shanghai for Healthy female
Mouse 120, weight be 19.0 ~ 21.8g, experimental animal production licence number be SCXK (Shanghai) 2013-0016, quality certification number:
2008001684293。
Mouse adapts to environment, is randomly divided into three big group by weight after quarantine 3 days, wherein I group mouse 40, it is randomly divided into
4 dosage groups, first carry out direct sleep experiments by every group 10, and next day carries out extending the experiment of yellow Jackets sleeping time again;Ⅱ
Group mouse 40 is randomly divided into 4 dosage groups, every group 10, carries out yellow Jackets sub-threshold dose hypnosis experiment;III group of mouse
40,4 dosage groups are randomly divided into, every group 10, carry out the experiment of barbital sodium Sleep latency.
Experimental animal is raised in this center barrier environment that temperature is 20 ~ 26 DEG C, relative humidity is 40% ~ 70%.Experiment
Animal uses credit number: SYXK (Soviet Union) 2015-0009.Irradiation sterilization feed cooperates with the limited duty of medical bioengineering by Jiangsu Province
Ren company provides, production licence: card (2014) 01008 is raised by Soviet Union.
Dosage selects to give mode with tested material: the human body recommended dose of given the test agent is the 2.4g/ day for human beings (with 60kg weight
Meter), if tri- 0.2g/ kgbw/d, 0.4 g/kg bw/d, 1.2g/ kgbw/d dosage groups (are respectively equivalent to tested
5 times, 10 times, 30 times of sample human body recommended intake), it sets 0g/kgbw/d group separately with sterile water and replaces tested material.Sample warp
It is prepared after crushing with sterile water, basic, normal, high dosage formulation concentration is respectively 20mg/mL, 40mg/mL, 120mg/mL, oral every
Once give the tested material of mouse corresponding dosage day, intragastric administration on mice amount is 01mL/10gbw.
Test method
1.4.1 the direct sleep experiments of mouse
Each dosage group animal continuous gavage one month is slept after the last administration with mouse righting reflex loss 1min to enter,
Righting reflex restores to be that mouse is awakened criterion, record each group sleep number of animals and sleeping time.
Compare control group and experimental group sleep number of animals and the difference between sleeping time, if when sleep number of animals or sleep
Between increase and have conspicuousness, then experimental result is positive.
Extend the experiment of yellow Jackets sleeping time
Each dosage group animal continuous gavage one month, after last dose 15min, groups of animals presses 45mg/kgbw dosage abdomen
Chamber injects yellow Jackets, and injection volume 10mL/kgbw rights disappearance 1min with mouse as sleep index, observes test sample
Can product extend yellow Jackets sleeping time.
Compare the difference between control group and the extension of experimental group sleeping time, sleeping time extension has conspicuousness, then tests
As a result positive.
Yellow Jackets sub-threshold dose hypnosis experiment
Each dosage group animal continuous gavage one month, after last dose 15min, groups of animals presses 30 mg/kg bw dosage
Yellow Jackets are injected intraperitoneally, injection volume 10mL/kgbw rights disappearance 1min with mouse as sleep index, records to penta
Each group sleep number of animals in barbital sodium 30min.
Compare the difference between control group and experimental group sleep number of animals, incidence of sleep animals increase has conspicuousness, then
Experimental result is positive.
The experiment of barbital sodium Sleep latency
Each dosage group animal continuous gavage one month, after last dose 15min, groups of animals presses 300mg/kgbw dosage abdomen
Chamber injects barbital sodium, and injection volume 10mL/kgbw rights disappearance 1min with mouse as sleep index, observes given the test agent
Influence to barbital sodium Sleep latency.
Compare the difference between control group and experimental group Sleep latency, Sleep latency shortening has conspicuousness, then tests
As a result positive.
Test data statistics: homogeneity test of variance is carried out to each test initial data with SPSS10.0 software, meets variance
The data information required together, with test groups multiple in one-way analysis of variance method between a control group mean two-by-two compared with
Method carries out statistical disposition;Variable conversion appropriate is carried out to the data information of Non-Gaussian Distribution or heterogeneity of variance, wait meet just
After state or variance require together, statistical disposition is carried out with resulting data are converted.
Result judgement: extend the experiment of yellow Jackets sleeping time, yellow Jackets sub-threshold dose hypnosis experiment, barbital
It is positive that sodium Sleep latency tests binomial in three experiments, and acts on without obvious directly sleep, can determine that the given the test agent has
Improve sleep function effect.
As a result: drinking water for animals is ingested normally in experimentation, and appearance is without exception.
Influence of the composition to mouse weight
Seen from table 1,02 g/kgbw/d of original body mass of mouse, 0.4 g/kgbw/d, 1.2g/kgbw/d group and 0
G/kgbw/d group compares, difference it is not statistically significant (P>0.05).Show that the original body mass of mouse is more equal between each group
Weighing apparatus.
Composition one month of orally administration mouse various dose, each dosage group weight gain are full through homogeneity test of variance
The requirement of sufficient homogeneity of variance, with experimental groups multiple in one-way analysis of variance method between a control group mean two-by-two relatively just
Method carries out statistical disposition.Seen from table 1,0.2g/kgbw/d, 0.4g/ kgbw/d, 1.2g/ kgbw/d group and 0g/
Kgbw/d group compares, difference it is not statistically significant (P>0.05)。
1 composition of table to mouse weight influence ()
。
The influence that composition directly sleeps to mouse
Phenomenon of sleeping does not occur for composition one month of orally administration mouse various dose, after the last administration, each group mouse.By
Table 2 is as it can be seen that composition 0.2g/kgbw/d, 0.4g/kgbw/d, 1.2g/kgbw/d group make mouse without directly sleep
With.
The influence that 2 composition of table directly sleeps to mouse
Influence of 2.3 compositions to yellow Jackets inducing mouse sleeping time is extended
Composition one month of orally administration mouse various dose is injected intraperitoneally yellow Jackets, observes the sleeping time of mouse.
Sleeping time through homogeneity test of variance, meets homogeneity of variance requirement, right with experimental groups multiple in one-way analysis of variance and one
Statistical disposition is carried out according to the comparative approach two-by-two of mean between group.By 3 result of table as it can be seen that when 1.2g/kgbw/d group mice sleep
Between be longer than 0g/kgbw/d group, difference is statistically significant (P < 0.05).
3 composition of table to extend yellow Jackets inducing mouse sleeping time influence ()
Influence of 2.4 compositions to dosage hypnosis under yellow Jackets
Yellow Jackets are injected intraperitoneally in composition one month of orally administration mouse various dose, observe each group mouse in 30min
Sleep incidence.Sleep number of animals carry out statistical disposition with exact propability.By 4 result of table as it can be seen that 0.2g/kgbw/d,
0.4g/ kgbw/d, 1.2g/kgbw/d group animal sleep incidence are compared with 0 g/kgbw/d group, no statistical difference
Meaning (P > 0.05).
4 composition of table yellow Jackets sub-threshold dose inducing mouse is slept close incidence influence ()
。
Influence of 2.5 compositions to barbital sodium Sleep latency
Composition one month of orally administration mouse various dose is injected intraperitoneally barbital sodium, observes the Sleep latency of mouse.
Sleep latency meets homogeneity of variance requirement through homogeneity test of variance, with experimental groups multiple in one-way analysis of variance method with
The comparative approach two-by-two of mean carries out statistical disposition between one control group.By 5 result of table as it can be seen that 0.4 g/kgbw/d, 1.2g/
Kgbw/d group mice sleep incubation period is significantly shorter than 0g/kgb/wd group, and difference is statistically significant (P < 0.05).
5 composition of table to barbital sodium Sleep latency influence ()
3 brief summaries
3.1 direct sleep experiments: 0.2 g/kgbw/d of composition, 0.4 g/kgbw/d, 1.2 g/kgbw/d groups are to small
Mouse acts on without direct sleep.Extend brave barbital sodium sleeping time experiment: 1.2g/ kgbw/d group mouse sleep time is long
In 0 g/kgbw/d group, difference is statistically significant (P < 0.05).
The eleventh of the twelve Earthly Branches barbital sodium sub-threshold dose hypnosis experiment: 0.2g/ kg bw/d, 04 g/kgbw/d, 1.2 g/kg
Bw/d group incidence of sleep animals are compared with 0g/kgbw/d group, no significant difference (P > 0.05).
Barbital sodium Sleep latency experiment: 0.4 g/kgbw/d, 1.2g/ kgbw/d group mice sleep incubation period
It is significantly shorter than 0g/ kgbw/d group, difference is statistically significant (P < 0.05).According to " health food is examined advises with assessment technique
Model " improvement sleep function test result judgement, under this experiment condition composition have the function of improvement sleep function.
Test example 2 --- animal experiment
Rhizoma Gastrodiae composition in the embodiment of the present invention 1 is tested by animal efficacy assessments, test portion is with test example 1, as a result
Display: the composition 1.2g/kg.bw/d test group mouse yellow Jackets sleeping time is longer than 0g/kg.bw/d control group;
0.4g/kg.bw/d and 1.2g/kg.bw/d test group mouse barbital sodium Sleep latency is shorter than 0g/kg.bw/d control group.From
And knowing that the composition has improves sleep function.It is tested by animal toxicology, test portion is with test example 1, as the result is shown:
The composition acute toxicity dosage is determined as nontoxic;It gives 100 times of rat human body recommended dose to feed for 30 days, not observe toxic
Evil effect;The test of animal deformity is feminine gender.
3-animal experiment of test example
The capsule of Rhizoma Gastrodiae composition in the embodiment of the present invention 4 is tested by animal efficacy assessments, test portion is the same as test
Example 1, as the result is shown: the composition 1.2g/kg.bw/d test group mouse yellow Jackets sleeping time is longer than 0g/kg.bw/d pairs
According to group;0.4g/kg.bw/d and 1.2g/kg.bw/d test group mouse barbital sodium Sleep latency is shorter than 0g/kg.bw/d control
Group.The composition, which has, to known to improves sleep function.It is tested by animal toxicology, test portion is with test example 1, as a result
Display: the composition acute toxicity dosage is determined as nontoxic;It gives 100 times of rat human body recommended dose to feed for 30 days, not observe
To toxic effect;The test of animal deformity is feminine gender.
4-animal experiment of test example
The capsule of Rhizoma Gastrodiae composition in the embodiment of the present invention 6 is tested by animal efficacy assessments, test portion is the same as test
Example 1, as the result is shown: the composition 1.2g/kg.bw/d test group mouse yellow Jackets sleeping time is longer than 0g/kg.bw/d pairs
According to group;0.4g/kg.bw/d and 1.2g/kg.bw/d test group mouse barbital sodium Sleep latency is shorter than 0g/kg.bw/d control
Group.The composition, which has, to known to improves sleep function.It is tested by animal toxicology, test portion is with test example 1, as a result
Display: the composition acute toxicity dosage is determined as nontoxic;It gives 100 times of rat human body recommended dose to feed for 30 days, not observe
To toxic effect;The test of animal deformity is feminine gender.
Test example 5 --- animal experiment
The tablet of Rhizoma Gastrodiae composition in the embodiment of the present invention 7 is tested by animal efficacy assessments, the same test example of test portion
1, as the result is shown: the composition 1.2g/kg.bw/d test group mouse yellow Jackets sleeping time is longer than 0g/kg.bw/d control
Group;0.4g/kg.bw/d and 1.2g/kg.bw/d test group mouse barbital sodium Sleep latency is shorter than 0g/kg.bw/d control
Group.The composition, which has, to known to improves sleep function.It is tested by animal toxicology, test portion is with test example 1, as a result
Display: the composition acute toxicity dosage is determined as nontoxic;It gives 100 times of rat human body recommended dose to feed for 30 days, not observe
To toxic effect;The test of animal deformity is feminine gender.
Test example 6 --- animal experiment
Capsule obtained in the embodiment of the present invention 10 is tested by animal efficacy assessments, test portion is with test example 1, as a result
Display: the composition 1.2g/kg.bw/d test group mouse yellow Jackets sleeping time is longer than 0g/kg.bw/d control group;
0.4g/kg.bw/d and 1.2g/kg.bw/d test group mouse barbital sodium Sleep latency is shorter than 0g/kg.bw/d control group.From
And knowing that the composition has improves sleep function.It is tested by animal toxicology, test portion is with test example 1, as the result is shown:
The composition acute toxicity dosage is determined as nontoxic;It gives 100 times of rat human body recommended dose to feed for 30 days, not observe toxic
Evil effect;The test of animal deformity is feminine gender.
Claims (10)
1. a kind of Rhizoma Gastrodiae composition for being effectively improved sleep, it is characterised in that the composition includes the raw material of following parts by weight:
4-16 parts of Rhizoma Gastrodiae extract, 16-33 parts of Wild jujube seeds extract, 13-33 parts of siberian Ginseng P.E, 8-25 parts of extract of licorice root.
2. the Rhizoma Gastrodiae composition according to claim 1 for being effectively improved sleep, it is characterised in that the composition include with
The raw material of lower parts by weight: 8-16 parts of Rhizoma Gastrodiae extract, 25-33 parts of Wild jujube seeds extract, 13-25 parts of siberian Ginseng P.E, Radix Glycyrrhizae
8-16 parts of medicinal extract, 10-30 parts of pregelatinized starch, 1.0-5.0 parts of croscarmellose sodium, 0.5-1.5 parts of silica, firmly
0.5-1.5 parts of fatty acid magnesium.
3. the Rhizoma Gastrodiae composition according to claim 1 for being effectively improved sleep, it is characterised in that the composition include with
The raw material of lower parts by weight: 8-16 parts of Rhizoma Gastrodiae extract, 25-33 parts of Wild jujube seeds extract, 13-25 parts of siberian Ginseng P.E, Radix Glycyrrhizae
8-16 parts of medicinal extract, 32-38 parts of microcrystalline cellulose, 2.0-3.0 parts of croscarmellose sodium, 6.0-10 parts of silica, firmly
6.0-10 parts of fatty acid magnesium, 2.5-3.5 parts of coating powder.
4. a kind of preparation method of the Rhizoma Gastrodiae composition for being effectively improved sleep any according to claim 1 ~ 3, feature
Be the following steps are included:
1) raw material preparation:
Take that meat is thick and solid, Gastrodia Elata Stem Tuber of no disease and pests harm, 55-65 DEG C low temperature drying 22-26 hours, crush, cross 8-12 mesh, add
The 8-12 times of 65-75% ethyl alcohol measured is Extraction solvent, and heating and refluxing extraction 2-4 times is 0.5-1.5 hours each, combined extract,
Ethyl alcohol is recovered under reduced pressure, is concentrated into and is equivalent to crude drug 0.4-0.6g/mL, 4000-6000 r/min is centrifuged 10-20 minutes, takes supernatant
Liquid is concentrated under reduced pressure into and is equivalent to crude drug 3-5g/mL, adds ethyl alcohol to alcohol content 65-75%, stands 22-26h, filtration adds 35-45%
NaOH solution tune pH value stands 22-26h, filtration to 8.0, and filtrate is concentrated under reduced pressure into paste in 45-55 DEG C and recycles ethyl alcohol,
45-55 DEG C or less vacuum drying, obtains Rhizoma Gastrodiae extract, spare;
Semen ziziphi spinosae seed is taken, is crushed into powder, adding the 7-9 times of 55-65% ethyl alcohol measured is Extraction solvent, is heated after impregnating 25-35 minutes
Refluxing extraction 2-4 hours, filtration;Add the 5-7 times of 55-65% ethyl alcohol measured for Extraction solvent, heating and refluxing extraction 1-3 times, every time
1.5-2.5 hour;Ethyl alcohol is recovered under reduced pressure in filtration, combined extract, and being concentrated into relative density is 1.20-1.24, adds ethyl alcohol to alcohol
Content 65-75% stands 22-26h, filtration, and filtrate is concentrated under reduced pressure into paste in 45-55 DEG C and recycles ethyl alcohol, and 45-55 DEG C
It is dried in vacuo below, obtains Wild jujube seeds extract, it is spare;
Wilsonii rhizome is taken, is cleaned out, is crushed into powder, adding the 8-12 times of 75-85% ethyl alcohol measured is Extraction solvent, is heated to reflux
It extracts 2-4 hours, filtration;Adding the 8-12 times of 70-80% ethyl alcohol measured is Extraction solvent, heating and refluxing extraction 1-3 times, each 1.5-
2.5 hour;Ethyl alcohol is recovered under reduced pressure in filtration, combined extract, and being concentrated into relative density is 1.20-1.24, adds ethyl alcohol to alcohol content
65-75% stands 22-26h, filtration, and filtrate is concentrated under reduced pressure into paste in 45-55 DEG C and recycles ethyl alcohol, and 45-55 DEG C or less true
Sky is dry, obtains siberian Ginseng P.E, spare;
It takes that matter is hard, taste is pure, Radix Glycyrrhizae without mildew, moisturizes, be sliced, add water to cook 2-4 time, 1.5-2.5 hour each, merging is pan-fried
Liquid, standing overnight makes to precipitate, and supernatant is taken to be concentrated into paste, and measurement liquiritin content must not be less than 0 .5%, and glycyrrhizic acid is not
It obtains and is less than 7.0%, obtain extract of licorice root, it is spare;
2) mix: by raw material obtained in step (1) first cross 60 meshes, then weigh respectively formula rate Rhizoma Gastrodiae extract,
Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root are sufficiently mixed uniformly.
5. a kind of preparation of the Rhizoma Gastrodiae composition for being effectively improved sleep any according to claim 1 ~ 3, it is characterised in that
The preparation is that the auxiliary material pharmaceutically received is added in the composition to be prepared into capsule, tablet, pulvis, particle
Agent, liquid preparation, pill.
6. a kind of preparation of the Rhizoma Gastrodiae composition according to claim 5 for being effectively improved sleep, it is characterised in that described
Capsule includes the raw material of following parts by weight: 8-16 parts of Rhizoma Gastrodiae extract, 25-33 parts of Wild jujube seeds extract, and siberian Ginseng P.E
13-25 parts, 8-16 parts of extract of licorice root, 10-30 parts of pregelatinized starch, 1.0-5.0 parts of croscarmellose sodium, silica
0.5-1.5 parts, 0.5-1.5 parts of magnesium stearate;The preparation method of the capsule the following steps are included:
1) it is sieved: Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root is crossed into 60 meshes respectively, it is spare;
2) it weighs: weighing Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, pregelatinated by formula rate
Starch, croscarmellose sodium, silica, magnesium stearate are spare;
3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, pregelatinized starch, crosslinking
Sodium carboxymethylcellulose, silica mix 25 ~ 35min, obtain mixed powder;
4) softwood processed: mixed powder softwood is added in 65-75% ethyl alcohol, additional amount is that 65-75% ethyl alcohol is added in every 100g mixed powder
28 ~ 32ml, be uniformly mixed, be allowed to hold it is agglomerating, gently pinch i.e. dissipate;
5) it pelletizes, dry, whole grain: the softwood made being pelletized by 16-20 mesh, then places 50 ~ 60 DEG C of dryings in baking oven
1.5 ~ 2.5h crosses 16-20 mesh sieve;
6) total mix: the particle after whole grain is mixed into 3 ~ 7min with magnesium stearate, obtains total hybrid particles;
7) capsule is filling: gained always being mixed granule filling, obtains capsule.
7. a kind of preparation of the Rhizoma Gastrodiae composition according to claim 6 for being effectively improved sleep, it is characterised in that described
The filling specification of capsule is 0.6g/, is filled in 0# capsule, and packing specification is 60/bottle, using the medicinal height of oral administration solid
Density polyethylene bottle is packed;The amount and eating method of the capsule be 2 times a day, 2 tablets each time, sooner or later each 1
It is secondary.
8. a kind of preparation of the Rhizoma Gastrodiae composition according to claim 5 for being effectively improved sleep, it is characterised in that described
Tablet includes the raw material of following parts by weight: 8-16 parts of Rhizoma Gastrodiae extract, 25-33 parts of Wild jujube seeds extract, and siberian Ginseng P.E 13-
25 parts, 8-16 parts of extract of licorice root, 32-38 parts of microcrystalline cellulose, 2.0-3.0 parts of croscarmellose sodium, silica
6.0-10 parts, 6.0-10 parts of magnesium stearate, 2.5-3.5 parts of coating powder;The preparation method of the tablet the following steps are included:
1) be sieved: Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root cross 60 meshes respectively, spare;
2) weigh: it is fine to weigh Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, crystallite by formula rate
It is spare to tie up element, croscarmellose sodium, silica, magnesium stearate, coating powder;
3) it mixes: first by Rhizoma Gastrodiae extract, Wild jujube seeds extract, siberian Ginseng P.E, extract of licorice root, microcrystalline cellulose, crosslinking
Sodium carboxymethylcellulose, silica mix 25 ~ 35min, obtain mixed powder;
4) softwood processed: mixed powder softwood is added in 65-75% ethyl alcohol, additional amount is that 65-75% ethyl alcohol is added in every 100g mixed powder
28 ~ 32ml, be allowed to hold it is agglomerating, gently pinch i.e. dissipate;
5) it pelletizes, dry, whole grain: the softwood made being pelletized by 16-20 mesh, then places 50 ~ 60 DEG C of dryings in baking oven
1.5 ~ 2.5h crosses 16-20 mesh sieve;
6) total mix: the particle after whole grain is mixed into 3 ~ 7min with magnesium stearate, obtains total hybrid particles;
7) granulation will always tabletting, coating, bottling: be mixed;Then coating powder is configured to 8-12% coating with 65-75% ethyl alcohol
Liquid is coated tabletting, coating weight gain 2-4%, bottling.
9. a kind of preparation of the Rhizoma Gastrodiae composition according to claim 8 for being effectively improved sleep, it is characterised in that described
The tabletting specification of tablet is 0.6g/ piece, and the bottling is to be carried out using oral stable medicinal polythene bottle with high density, bottling rule
Lattice are 80 pieces/bottle;The amount and eating method of the tablet: 2 times a day, 2 tablets once, and each 1 time sooner or later.
10. a kind of application with the Rhizoma Gastrodiae composition for improving function any according to claim 1 ~ 3, it is characterised in that
Application of the Rhizoma Gastrodiae composition on prevention/auxiliary treatment of insomnia disease.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811155340.6A CN109125617A (en) | 2018-09-30 | 2018-09-30 | A kind of Rhizoma Gastrodiae composition being effectively improved sleep and preparation method, preparation and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811155340.6A CN109125617A (en) | 2018-09-30 | 2018-09-30 | A kind of Rhizoma Gastrodiae composition being effectively improved sleep and preparation method, preparation and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109125617A true CN109125617A (en) | 2019-01-04 |
Family
ID=64814025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811155340.6A Pending CN109125617A (en) | 2018-09-30 | 2018-09-30 | A kind of Rhizoma Gastrodiae composition being effectively improved sleep and preparation method, preparation and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109125617A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107997174A (en) * | 2017-12-14 | 2018-05-08 | 汤臣倍健股份有限公司 | A kind of health composition and health food for having effects that to improve sleep and/or antidepression |
-
2018
- 2018-09-30 CN CN201811155340.6A patent/CN109125617A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107997174A (en) * | 2017-12-14 | 2018-05-08 | 汤臣倍健股份有限公司 | A kind of health composition and health food for having effects that to improve sleep and/or antidepression |
Non-Patent Citations (3)
Title |
---|
姜涛等: "刺五加和天麻素联合应用治疗失眠症的疗效观察", 《中国伤残医学》 * |
洪燕龙等: "天麻提取物的提取、纯化工艺研究", 《中成药》 * |
程嘉艺: "《药食同源中药材药理研究与应用》", 31 March 2018, 辽宁科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102940768B (en) | Composition for improving sleep and preparation method and application thereof | |
CN101396466A (en) | Cold medicine tea composition as medicine and food, preparation method and use thereof | |
CN106692297A (en) | Composition for assistedly decreasing blood sugar, and preparation method and application thereof | |
CN106176918A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Radix Puerariae | |
CN1947757B (en) | Leave of glutinous rehmannia extractive, its preparation method and use, medicines prepared with said extractives | |
CN116158529A (en) | Functional food composition with auxiliary uric acid reducing and gout relieving effects | |
CN104435299B (en) | A kind of Chinese medicine composition for improving the health care of sleep and preparation method thereof | |
CN105055855B (en) | With Chinese medicine composition for improving sleep, strengthen immunity effect and its preparation method and application | |
CN104474135B (en) | A kind of pharmaceutical composition to chemical damage with assistant protection function | |
CN101856418B (en) | Pharmaceutical preparation for preventing nephritis and preparation method thereof | |
CN104383447B (en) | A kind of Traditional Chinese medicine composition and preparation method and application | |
CN104922216B (en) | A kind of pharmaceutical composition of defaecation and preparation method thereof | |
CN103550398B (en) | Composition for relieving fatigue as well as preparation method and medical application thereof | |
CN101356972A (en) | Anti-fatigue anti-hypoxia sports health food | |
CN101804123B (en) | Plant raw material composition with anti-fatigue effect, preparation method, application and product thereof | |
CN110123974A (en) | A kind of composition that treating hyperuricemia and preparation method | |
CN109125617A (en) | A kind of Rhizoma Gastrodiae composition being effectively improved sleep and preparation method, preparation and application | |
CN110051817A (en) | A kind of Chinese traditional medicine composition and its application reducing uric acid | |
CN101829272B (en) | Traditional Chinese medicine composition for treating diabetes mellitus and preparation method thereof | |
CN104664011B (en) | A kind of composition with clearing healthcare function and preparation method thereof | |
CN107778340A (en) | (20S, 24R) 20,24 epoxy dammarane 3 β, 12 β, 25 triols and its application | |
CN107050143A (en) | It is a kind of that there is the formula for improving sleep effect, composition and preparation method thereof | |
CN106421741A (en) | Water-soluble olive leaf extract health-care product and preparation method thereof | |
AU2016313671A1 (en) | Health food and process for preparing the same | |
CN114010676A (en) | Composition for reducing blood fat and improving memory and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190104 |
|
RJ01 | Rejection of invention patent application after publication |